{ "version": "2.2", "instance": { "mpw-20230930.htm": { "nsprefix": "mpw", "nsuri": "http://medicalpropertiestrust.com/20230930", "dts": { "inline": { "local": [ "mpw-20230930.htm" ] }, "schema": { "local": [ "mpw-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "mpw-20230930_cal.xml" ] }, "definitionLink": { "local": [ "mpw-20230930_def.xml" ] }, "labelLink": { "local": [ "mpw-20230930_lab.xml" ] }, "presentationLink": { "local": [ "mpw-20230930_pre.xml" ] } }, "keyStandard": 212, "keyCustom": 120, "axisStandard": 32, "axisCustom": 0, "memberStandard": 49, "memberCustom": 87, "hidden": { "total": 19, "http://xbrl.sec.gov/dei/2023": 8, "http://fasb.org/us-gaap/2023": 11 }, "contextCount": 539, "entityCount": 1, "segmentCount": 148, "elementCount": 688, "unitCount": 15, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 1227, "http://xbrl.sec.gov/ecd/2023": 4, "http://xbrl.sec.gov/dei/2023": 54, "http://fasb.org/srt/2023": 1 }, "report": { "R1": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R2": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "longName": "100010 - Statement - Condensed Consolidated Balance Sheets", "shortName": "Condensed Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "mpw:LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "mpw:LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R3": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical", "longName": "100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R4": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited", "longName": "100030 - Statement - Condensed Consolidated Statements of Net Income (Unaudited)", "shortName": "Condensed Consolidated Statements of Net Income (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "C_3ad46c82-90f6-4090-a0ab-4c9f31df74af", "name": "mpw:RentBilled", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_3ad46c82-90f6-4090-a0ab-4c9f31df74af", "name": "mpw:RentBilled", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R5": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "longName": "100040 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)", "shortName": "Condensed Consolidated Statements of Comprehensive Income (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "C_3ad46c82-90f6-4090-a0ab-4c9f31df74af", "name": "us-gaap:ProfitLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R6": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "longName": "100050 - Statement - Condensed Consolidated Statements of Equity / Capital", "shortName": "Condensed Consolidated Statements of Equity / Capital", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "C_4d48a930-8725-401d-8179-df9f3378b318", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_b9cf774f-825f-41fa-9c1c-9010cd78c27a", "name": "us-gaap:ProfitLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R7": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical", "longName": "100060 - Statement - Condensed Consolidated Statements of Equity / Capital (Parenthetical)", "shortName": "Condensed Consolidated Statements of Equity / Capital (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "C_3ad46c82-90f6-4090-a0ab-4c9f31df74af", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_a88faa19-464e-4074-9a0c-bee3a5de5f4d", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R8": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "longName": "100070 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:ProfitLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R9": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "C_3ad46c82-90f6-4090-a0ab-4c9f31df74af", "name": "us-gaap:NetIncomeLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": null }, "R10": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R11": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureOrganization", "longName": "995455 - Disclosure - Organization", "shortName": "Organization", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R12": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies", "longName": "995465 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R13": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities", "longName": "995475 - Disclosure - Real Estate and Other Activities", "shortName": "Real Estate and Other Activities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:RealEstateDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:RealEstateDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R14": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebt", "longName": "995485 - Disclosure - Debt", "shortName": "Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:LongTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:LongTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R15": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureIncomeTaxes1", "longName": "995495 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R16": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureStockAwards", "longName": "995505 - Disclosure - Stock Awards", "shortName": "Stock Awards", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R17": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstruments", "longName": "995515 - Disclosure - Fair Value of Financial Instruments", "shortName": "Fair Value of Financial Instruments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R18": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnit", "longName": "995525 - Disclosure - Earnings Per Share/Unit", "shortName": "Earnings Per Share/Unit", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R19": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies", "longName": "995535 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R20": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies", "longName": "995545 - Disclosure - Summary of Significant Accounting Policies (Policies)", "shortName": "Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "20", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R21": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables", "longName": "995555 - Disclosure - Summary of Significant Accounting Policies (Tables)", "shortName": "Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "21", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:ConsolidationVariableInterestEntityPolicy", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:ConsolidationVariableInterestEntityPolicy", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R22": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables", "longName": "995565 - Disclosure - Real Estate and Other Activities (Tables)", "shortName": "Real Estate and Other Activities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R23": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtTables", "longName": "995575 - Disclosure - Debt (Tables)", "shortName": "Debt (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R24": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables", "longName": "995585 - Disclosure - Fair Value of Financial Instruments (Tables)", "shortName": "Fair Value of Financial Instruments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R25": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnitTables", "longName": "995595 - Disclosure - Earnings Per Share/Unit (Tables)", "shortName": "Earnings Per Share/Unit (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R26": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "longName": "995605 - Disclosure - Organization - Additional Information (Detail)", "shortName": "Organization - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "mpw:PercentageOfLeasedAssetsOwned", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "mpw:PercentageOfLeasedAssetsOwned", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R27": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails", "longName": "995615 - Disclosure - Summary of Significant Accounting Policies - Summary of Carrying Value and Classification of the Assets and Maximum Exposure (Details)", "shortName": "Summary of Significant Accounting Policies - Summary of Carrying Value and Classification of the Assets and Maximum Exposure (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "C_9a723945-ea65-4b09-9576-e1d9bf32592d", "name": "us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:ConsolidationVariableInterestEntityPolicy", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_9a723945-ea65-4b09-9576-e1d9bf32592d", "name": "us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:ConsolidationVariableInterestEntityPolicy", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R28": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "longName": "995635 - Disclosure - Real Estate and Other Activities - Net Assets Acquired (Detail)", "shortName": "Real Estate and Other Activities - Net Assets Acquired (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_5b1352b8-a33c-4282-9a4f-b700b626d983", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R29": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "longName": "995645 - Disclosure - Real Estate and Other Activities - Net Assets Acquired (Parenthetical) (Detail)", "shortName": "Real Estate and Other Activities - Net Assets Acquired (Parenthetical) (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "mpw:BusinessCombinationLoansPaidDownOnAcquisitionLoans", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_aadfe077-3e10-48b3-958c-4d74d890ced1", "name": "mpw:BusinessCombinationLoansPaidDownOnAcquisitionLoans", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "link:footnote", "div", "div", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R30": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "longName": "995655 - Disclosure - Real Estate and Other Activities - 2023 Activity - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - 2023 Activity - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "C_ca6cf28f-e74d-4cf3-8585-f41c5fba5b11", "name": "us-gaap:ImpairmentOfRealEstate", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_3099d645-9f95-4700-bb51-3de0f52713c2", "name": "mpw:CapitalRestructuringCosts", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R31": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "longName": "995665 - Disclosure - Real Estate and Other Activities - 2022 Activity - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - 2022 Activity - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "C_43bb6608-119d-435c-b1ce-98f689519f18", "name": "us-gaap:GainLossOnDispositionOfRealEstateDiscontinuedOperations", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_cbe28197-7f50-4e68-821b-4b29c3e1122f", "name": "mpw:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesAndOtherLiabilities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R32": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "longName": "995675 - Disclosure - Real Estate and Other Activities - Development Activities - Summary of Status on Current Development Projects (Detail)", "shortName": "Real Estate and Other Activities - Development Activities - Summary of Status on Current Development Projects (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "mpw:DevelopmentProjectsOriginalCommitmentAmount", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfDevelopmentProjectsTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "mpw:DevelopmentProjectsOriginalCommitmentAmount", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfDevelopmentProjectsTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R33": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "longName": "995685 - Disclosure - Real Estate and Other Activities - Disposals - 2023 Activity Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Disposals - 2023 Activity Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "C_43bb6608-119d-435c-b1ce-98f689519f18", "name": "mpw:NumberOfFacilitiesSold", "unitRef": "U_Facility", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_ca6cf28f-e74d-4cf3-8585-f41c5fba5b11", "name": "mpw:EstimatedFeesToSellTheHospitals", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R34": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "longName": "995695 - Disclosure - Real Estate and Other Activities - Disposals - 2022 Activity - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Disposals - 2022 Activity - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "C_43bb6608-119d-435c-b1ce-98f689519f18", "name": "us-gaap:GainLossOnDispositionOfRealEstateDiscontinuedOperations", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_43bb6608-119d-435c-b1ce-98f689519f18", "name": "mpw:NumberOfAncillaryPropertiesSold", "unitRef": "U_Property", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R35": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "longName": "995705 - Disclosure - Real Estate and Other Activities - Summary of Operating Results from Properties Sold (Details)", "shortName": "Real Estate and Other Activities - Summary of Operating Results from Properties Sold (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "C_3ad46c82-90f6-4090-a0ab-4c9f31df74af", "name": "us-gaap:Revenues", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_c9ddaf1e-f2a2-45a2-bd7e-98153a090255", "name": "us-gaap:Revenues", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:SummaryOfOperatingResultsFromPropertiesTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R36": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails", "longName": "995715 - Disclosure - Real Estate and Other Activities - Summary of Operating Results from Properties Sold (Parenthetical) (Details)", "shortName": "Real Estate and Other Activities - Summary of Operating Results from Properties Sold (Parenthetical) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "C_ca6cf28f-e74d-4cf3-8585-f41c5fba5b11", "name": "us-gaap:ImpairmentOfRealEstate", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_01a6ba49-f36b-4247-a865-96abcbbebc9d", "name": "us-gaap:GainLossOnSaleOfInvestments", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "div", "div", "mpw:SummaryOfOperatingResultsFromPropertiesTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R37": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail", "longName": "995725 - Disclosure - Real Estate and Other Activities - Leasing Operations (Lessor) - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Leasing Operations (Lessor) - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "us-gaap:LessorOperatingLeaseRenewalTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "us-gaap:LessorOperatingLeaseRenewalTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R38": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail", "longName": "995735 - Disclosure - Real Estate and Other Activities - Components of Total Investment in Financing Leases (Detail)", "shortName": "Real Estate and Other Activities - Components of Total Investment in Financing Leases (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "us-gaap:DirectFinancingLeaseLeaseReceivable", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "us-gaap:DirectFinancingLeaseLeaseReceivable", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R39": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetails", "longName": "995745 - Disclosure - Real Estate and Other Activities - Other Leasing Activities - Additional Information (Details)", "shortName": "Real Estate and Other Activities - Other Leasing Activities - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "mpw:PercentageOfPropertiesOccupiedByTenants", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "mpw:PercentageOfPropertiesOccupiedByTenants", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R40": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesCoronavirusCovid19RentDeferralsAdditionalInformationDetail", "longName": "995755 - Disclosure - Real Estate and Other Activities - Coronavirus (COVID-19) Rent Deferrals - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Coronavirus (COVID-19) Rent Deferrals - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "mpw:RemainingOutstandingDeferredRentToBeReceived", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "mpw:RemainingOutstandingDeferredRentToBeReceived", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R41": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "longName": "995765 - Disclosure - Real Estate and Other Activities - Pipeline Health System - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Pipeline Health System - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "C_0714cb78-863e-4588-aa5b-a50774fb355c", "name": "us-gaap:DeferredRentReceivablesNet", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0714cb78-863e-4588-aa5b-a50774fb355c", "name": "us-gaap:DeferredRentReceivablesNet", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R42": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "longName": "995775 - Disclosure - Real Estate and Other Activities - Steward Health Care System - Additional Information (Details)", "shortName": "Real Estate and Other Activities - Steward Health Care System - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "C_6bc7a48d-a710-42f3-8b34-6470ae7c2e6d", "name": "us-gaap:LesseeOperatingLeaseTermOfContract", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_6bc7a48d-a710-42f3-8b34-6470ae7c2e6d", "name": "us-gaap:LesseeOperatingLeaseTermOfContract", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R43": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "longName": "995785 - Disclosure - Real Estate and Other Activities - Alecto Healthcare Services LLC - Additional Information (Details)", "shortName": "Real Estate and Other Activities - Alecto Healthcare Services LLC - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "C_ca08c62b-034d-45ab-817b-a06eaed71310", "name": "mpw:NumberOfPropertiesLeased", "unitRef": "U_Property", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ca08c62b-034d-45ab-817b-a06eaed71310", "name": "mpw:NumberOfPropertiesLeased", "unitRef": "U_Property", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R44": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "longName": "995795 - Disclosure - Real Estate and Other Activities - Prospect - Additional Information) (Details)", "shortName": "Real Estate and Other Activities - Prospect - Additional Information) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "C_3ad46c82-90f6-4090-a0ab-4c9f31df74af", "name": "us-gaap:Revenues", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_e675fed9-451a-4f3c-87c2-c5accce8ce6a", "name": "mpw:RentalRevenue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R45": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherTenantUpdatesAdditionalInformationDetails", "longName": "995805 - Disclosure - Real Estate and Other Activities - Other Tenant Updates - Additional Information (Details)", "shortName": "Real Estate and Other Activities - Other Tenant Updates - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "C_ca6cf28f-e74d-4cf3-8585-f41c5fba5b11", "name": "mpw:StraightLineRentReceivables", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_6508a128-2c07-425b-8696-33f02079748c", "name": "mpw:NumberOfFacilitiesHeldForSale", "unitRef": "U_Facility", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R46": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "longName": "995815 - Disclosure - Real Estate and Other Activities - Investments in Unconsolidated Real Estate Joint Ventures - Additional Information (Details)", "shortName": "Real Estate and Other Activities - Investments in Unconsolidated Real Estate Joint Ventures - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "C_f7ffe791-93c4-4d25-853d-d52d20244e47", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_f7ffe791-93c4-4d25-853d-d52d20244e47", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R47": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "longName": "995825 - Disclosure - Real Estate and Other Activities - Summary of Investments in Unconsolidated Real Estate Joint Ventures by Operator (Details)", "shortName": "Real Estate and Other Activities - Summary of Investments in Unconsolidated Real Estate Joint Ventures by Operator (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "us-gaap:RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_b31db93e-bb49-4a60-9b72-02011c59114e", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:SummaryOfInvestmentsInUnconsolidatedOperatingEntitiesTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R48": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "longName": "995835 - Disclosure - Real Estate and Other Activities - Summary of Investments in Unconsolidated Operating Entities (Details)", "shortName": "Real Estate and Other Activities - Summary of Investments in Unconsolidated Operating Entities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "mpw:InvestmentsInUnconsolidatedOperatingEntities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_a12d938f-e20e-4a83-861e-ec9feaab8780", "name": "mpw:InvestmentsInUnconsolidatedOperatingEntities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R49": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail", "longName": "995845 - Disclosure - Real Estate and Other Activities - Investments in Unconsolidated Operating Entities - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Investments in Unconsolidated Operating Entities - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "C_ad46ef26-e524-4b94-b19a-c5d3f6b7a4de", "name": "mpw:FavorableFairMarketValueAdjustmentOnInvestment", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ad46ef26-e524-4b94-b19a-c5d3f6b7a4de", "name": "mpw:FavorableFairMarketValueAdjustmentOnInvestment", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R50": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "longName": "995855 - Disclosure - Real Estate and Other Activities - Other Investment Activities - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Other Investment Activities - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "C_84e74448-f890-4f15-bef7-ea464cd4b056", "name": "mpw:RepaymentsOfMortgageLoan", "unitRef": "U_CHF", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_84e74448-f890-4f15-bef7-ea464cd4b056", "name": "mpw:RepaymentsOfMortgageLoan", "unitRef": "U_CHF", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R51": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfActivityInCreditLossReservesDetails", "longName": "995865 - Disclosure - Real Estate and Other Activities - Summary of Activity in Credit Loss Reserves (Details)", "shortName": "Real Estate and Other Activities - Summary of Activity in Credit Loss Reserves (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "C_d035d88e-4cd0-452e-88ac-ea5bdc15f6e8", "name": "us-gaap:FinancingReceivableAllowanceForCreditLosses", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:SummaryOfCreditLossReservesTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d035d88e-4cd0-452e-88ac-ea5bdc15f6e8", "name": "us-gaap:FinancingReceivableAllowanceForCreditLosses", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:SummaryOfCreditLossReservesTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R52": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesCreditLossReservesAdditionalInformationDetails", "longName": "995875 - Disclosure - Real Estate and Other Activities - Credit Loss Reserves - Additional Information (Details)", "shortName": "Real Estate and Other Activities - Credit Loss Reserves - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "C_52935edf-8704-4db0-b491-e2184b3a8473", "name": "us-gaap:ProvisionForLoanLeaseAndOtherLosses", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_52935edf-8704-4db0-b491-e2184b3a8473", "name": "us-gaap:ProvisionForLoanLeaseAndOtherLosses", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R53": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "longName": "995885 - Disclosure - Real Estate and Other Activities - Schedule of Concentrations of Credit Risk (Details)", "shortName": "Real Estate and Other Activities - Schedule of Concentrations of Credit Risk (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "us-gaap:Assets", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_28f43c27-152b-42a9-a782-aed0f11498a7", "name": "us-gaap:Assets", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R54": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "longName": "995895 - Disclosure - Real Estate and Other Activities - Schedule of Concentrations of Credit Risk (Parenthetical) (Details)", "shortName": "Real Estate and Other Activities - Schedule of Concentrations of Credit Risk (Parenthetical) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "C_c8b6db74-2e87-47a3-97f8-a59fd14d7f7f", "name": "mpw:EstimatedConcentrationRiskPercentage", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "span", "link:footnote", "div", "div", "ix:continuation", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_c8b6db74-2e87-47a3-97f8-a59fd14d7f7f", "name": "mpw:EstimatedConcentrationRiskPercentage", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "span", "link:footnote", "div", "div", "ix:continuation", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R55": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "longName": "995905 - Disclosure - Debt - Summary of Debt (Detail)", "shortName": "Debt - Summary of Debt (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "us-gaap:DeferredFinanceCostsNet", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R56": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail", "longName": "995915 - Disclosure - Debt - Summary of Debt (Parenthetical) (Detail)", "shortName": "Debt - Summary of Debt (Parenthetical) (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_dc02005f-df14-477d-8cd5-9a2beac94b02", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "U_GBP", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "link:footnote", "div", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R57": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail", "longName": "995925 - Disclosure - Debt - Principal Payments Due for Debt (Detail)", "shortName": "Debt - Principal Payments Due for Debt (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R58": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "longName": "995935 - Disclosure - Debt - 2023 Activity - Additional Information (Details)", "shortName": "Debt - 2023 Activity - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "C_43bb6608-119d-435c-b1ce-98f689519f18", "name": "mpw:NumberOfFacilitiesSold", "unitRef": "U_Facility", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_6436e0c5-402a-4f10-b45c-b5d553523641", "name": "us-gaap:DeferredFinanceCostsGross", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R59": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2022ActivityAdditionalInformationDetail", "longName": "995945 - Disclosure - Debt - 2022 Activity - Additional Information (Detail)", "shortName": "Debt - 2022 Activity - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:LineOfCreditFacilityInitiationDate1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:LineOfCreditFacilityInitiationDate1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R60": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "longName": "995955 - Disclosure - Debt - Additional Information (Detail)", "shortName": "Debt - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "mpw:DebtRefinancingCharge", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_715df254-1a76-40f0-875b-ceb5ec54ea2f", "name": "mpw:DebtRefinancingCharge", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R61": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail", "longName": "995965 - Disclosure - Debt - Covenants - Additional Information (Detail)", "shortName": "Debt - Covenants - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "mpw:PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "mpw:PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R62": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "longName": "995975 - Disclosure - Income Taxes - Additional Information (Detail)", "shortName": "Income Taxes - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "C_3ad46c82-90f6-4090-a0ab-4c9f31df74af", "name": "us-gaap:IncomeTaxExpenseBenefit", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_ca6cf28f-e74d-4cf3-8585-f41c5fba5b11", "name": "mpw:IncomeTaxBenefitRelatedToTheInitialLoanImpairment", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R63": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "longName": "995985 - Disclosure - Stock Awards - Additional Information (Detail)", "shortName": "Stock Awards - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "C_d59d2095-d114-4693-b4fb-1dea863333d3", "name": "us-gaap:ShareBasedCompensation", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_f84c4694-ebef-47e0-9453-b70f92b3f66e", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R64": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail", "longName": "995995 - Disclosure - Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Detail)", "shortName": "Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "mpw:InterestAndRentReceivable", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "mpw:Loans", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R65": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "longName": "996005 - Disclosure - Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Parenthetical) (Detail)", "shortName": "Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Parenthetical) (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "C_75e253c1-7202-4c27-b81c-32ee6607ce8a", "name": "us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_1e3c6c96-122c-4f5c-9515-34d0dd82001e", "name": "mpw:InvestmentsInUnconsolidatedOperatingEntities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "div", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R66": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "longName": "996015 - Disclosure - Fair Value of Financial Instruments - Additional Information (Detail)", "shortName": "Fair Value of Financial Instruments - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "C_a54e2fe5-7b50-458d-9d2e-21c0d9b23c1a", "name": "mpw:DiscountForLackOfMarketabilityPercentage", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:ScheduleOfSensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": null }, "R67": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "longName": "996025 - Disclosure - Fair Value of Financial Instruments - Equity Interest in Related Party and Related Loans Measured at Fair Value on Recurring Basis (Detail)", "shortName": "Fair Value of Financial Instruments - Equity Interest in Related Party and Related Loans Measured at Fair Value on Recurring Basis (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "C_4c989817-2211-4e4f-bfe1-83fbbb283afd", "name": "us-gaap:InvestmentOwnedAtFairValue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4c989817-2211-4e4f-bfe1-83fbbb283afd", "name": "us-gaap:InvestmentOwnedAtFairValue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R68": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDlomBySensitivityAnalysisByUsingBasisPointVariationsDetails", "longName": "996035 - Disclosure - Fair Value of Financial Instruments - Schedule of Effects of Movement in DLOM by Sensitivity Analysis by Using Basis Point Variations (Details)", "shortName": "Fair Value of Financial Instruments - Schedule of Effects of Movement in DLOM by Sensitivity Analysis by Using Basis Point Variations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "C_a9fbef9a-9573-4dbe-80a1-2330957c5753", "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfSensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_a9fbef9a-9573-4dbe-80a1-2330957c5753", "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfSensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true, "unique": true } }, "R69": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "longName": "996045 - Disclosure - Earnings Per Share/Unit - Calculation of Earnings Per Share (Detail)", "shortName": "Earnings Per Share/Unit - Calculation of Earnings Per Share (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "C_3ad46c82-90f6-4090-a0ab-4c9f31df74af", "name": "us-gaap:ProfitLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_3ad46c82-90f6-4090-a0ab-4c9f31df74af", "name": "mpw:UndistributedEarningAllocatedToParticipatingSecurities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } }, "R70": { "role": "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "longName": "996055 - Disclosure - Commitments and Contingencies - Additional Information (Detail)", "shortName": "Commitments and Contingencies - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "C_43bb6608-119d-435c-b1ce-98f689519f18", "name": "mpw:NumberOfFacilitiesSold", "unitRef": "U_Facility", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_3e42c438-bfe9-4978-949c-2b43ab4b3272", "name": "mpw:NumberOfFacilitiesSold", "unitRef": "U_Facility", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20230930.htm", "unique": true } } }, "tag": { "mpw_PrimeHealthcareServicesIncFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PrimeHealthcareServicesIncFacilitiesMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Prime Healthcare Services, Inc. Facilities [Member]", "label": "Prime Healthcare Services, Inc. Facilities [Member]", "documentation": "Prime Healthcare Services, Inc. facilities." } } }, "auth_ref": [] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "auth_ref": [ "r780" ] }, "mpw_CatholicHealthInitiativesColoradoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "CatholicHealthInitiativesColoradoMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Catholic health initiatives colorado.", "label": "Catholic Health Initiatives Colorado [Member]", "terseLabel": "Catholic Health Initiatives Colorado [Member]" } } }, "auth_ref": [] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r739", "r750", "r760", "r785" ] }, "mpw_PurchaseOfNonControllingInterestOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PurchaseOfNonControllingInterestOfShares", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition of Non-Controlling Interest (Shares)", "label": "Purchase Of Non Controlling Interest Of Shares", "documentation": "Purchase Of Non Controlling Interest of shares" } } }, "auth_ref": [] }, "mpw_DebtAndEquitySecuritiesReceivedForCertainObligationsRealEstateAndRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "DebtAndEquitySecuritiesReceivedForCertainObligationsRealEstateAndRevenue", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "documentation": "Debt and equity securities received for certain obligations, real estate, and revenue.", "label": "Debt and equity securities received for certain obligations, real estate, and revenue", "terseLabel": "Debt and equity securities received for certain obligations, real estate, and revenue" } } }, "auth_ref": [] }, "mpw_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Long Term Debt Maturities Repayments Of Principal After Year Four", "documentation": "Long term debt maturities repayments of principal after year four." } } }, "auth_ref": [] }, "mpw_TaxRateChanges": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "TaxRateChanges", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "documentation": "Tax rate changes", "label": "Tax rate changes", "terseLabel": "Tax rate changes and other" } } }, "auth_ref": [] }, "mpw_TwoPointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "TwoPointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2.500% Senior Unsecured Notes due 2026 [Member]", "label": "Two Point Five Zero Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Six [Member]", "documentation": "Two point five zero zero percentage senior unsecured notes due two thousand twenty six." } } }, "auth_ref": [] }, "mpw_ReservesOnStraightLineRentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "ReservesOnStraightLineRentReceivables", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reserves on straight line rent receivables", "label": "Reserves On Straight Line Rent Receivables", "documentation": "Reserves on straight line rent receivables." } } }, "auth_ref": [] }, "mpw_CostsOfLeasedAndRentedPropertyOrEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "CostsOfLeasedAndRentedPropertyOrEquipment", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Property-related", "label": "Costs Of Leased And Rented Property Or Equipment", "documentation": "Costs of leased and rented property or equipment." } } }, "auth_ref": [] }, "mpw_LoansTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "LoansTwoMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "documentation": "Loans two.", "label": "Loans Two [Member]", "terseLabel": "Loans, Net Two [Member]" } } }, "auth_ref": [] }, "mpw_SpringstoneHealthOpcoLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "SpringstoneHealthOpcoLlcMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Springstone Health Opco, LLC.", "label": "Springstone Health Opco, LLC [Member]", "terseLabel": "Springstone Health Opco, LLC [Member]" } } }, "auth_ref": [] }, "mpw_NetIncomeLessParticipatingSecuritiesShareInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "NetIncomeLessParticipatingSecuritiesShareInEarnings", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Net income, less participating securities' share in earnings", "label": "Net Income Less Participating Securities Share In Earnings", "documentation": "Net income less participating securities share in earnings." } } }, "auth_ref": [] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "auth_ref": [ "r780" ] }, "mpw_AcquisitionLoansAndOtherLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "AcquisitionLoansAndOtherLoans", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other loans", "label": "Acquisition Loans And Other Loans", "documentation": "Acquisition loans and other loans." } } }, "auth_ref": [] }, "mpw_NumberOfDirectFinancingLeases": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "NumberOfDirectFinancingLeases", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Number of direct financing leases", "label": "Number Of Direct Financing Leases", "documentation": "Number of direct financing leases." } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total comprehensive income", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r83", "r135", "r200", "r202", "r208", "r532", "r554" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r767" ] }, "mpw_EquityInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "EquityInvestment", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Equity investment.", "label": "Equity Investment", "terseLabel": "Equity investment" } } }, "auth_ref": [] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "auth_ref": [ "r780" ] }, "mpw_OtherLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "OtherLoansMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Other Loans [Member]", "label": "Other Loans [Member]", "documentation": "Other Loans" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Tangible Asset", "label": "Long-Lived Tangible Asset [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r127" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "auth_ref": [ "r736", "r747", "r757", "r782" ] }, "mpw_StewardLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "StewardLoanMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Steward Loan Investment.", "label": "Steward Loan Investment [Member]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Equity / Capital", "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Comprehensive income attributable to non-controlling interests", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive loss (income) attributable to non-controlling interests", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r8", "r68", "r83", "r200", "r202", "r209", "r533", "r555" ] }, "mpw_AllOtherStatesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "AllOtherStatesMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "All other states.", "label": "All Other States [Member]", "terseLabel": "All Other States [Member]" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupClassificationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group Classification [Domain]", "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations." } } }, "auth_ref": [] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "auth_ref": [ "r780" ] }, "mpw_OtherOperatorsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "OtherOperatorsMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "Other operators.", "label": "Other Operators [Member]", "terseLabel": "Other Operators [Member]" } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "auth_ref": [ "r745", "r753", "r763", "r780", "r788", "r792", "r800" ] }, "mpw_AdvancementOfRedevelopmentRecoveryReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "AdvancementOfRedevelopmentRecoveryReceivables", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Advancement of redevelopment recovery receivables.", "label": "Advancement Of Redevelopment Recovery Receivables", "terseLabel": "Advancement of redevelopment recovery receivables" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfOtherShortTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfOtherShortTermDebt", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Repayment received on credit facility availed", "label": "Repayments of Other Short-Term Debt", "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing within one year or the operating cycle, if longer." } } }, "auth_ref": [ "r38" ] }, "us-gaap_DisposalGroupClassificationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group Classification [Axis]", "documentation": "Information by disposal group classification." } } }, "auth_ref": [ "r186" ] }, "mpw_SupplementalScheduleOfNonCashFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "SupplementalScheduleOfNonCashFinancingActivitiesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental schedule of non-cash financing activities:", "label": "Supplemental Schedule Of Non Cash Financing Activities [Abstract]", "documentation": "Supplemental Schedule Of Non Cash Financing Activities [Abstract]" } } }, "auth_ref": [] }, "mpw_UnsecuredRevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "UnsecuredRevolvingCreditFacilityMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Unsecured Revolving Credit Facility [Member]", "label": "Unsecured Revolving Credit Facility [Member]", "documentation": "Unsecured Revolving Credit Facility [Member]" } } }, "auth_ref": [] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "auth_ref": [ "r745", "r753", "r763", "r780", "r788", "r792", "r800" ] }, "us-gaap_LandAndLandImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LandAndLandImprovementsMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Land and Land Improvements [Member]", "label": "Land and Land Improvements [Member]", "documentation": "Real estate held and assets that are an addition or improvement to real estate held." } } }, "auth_ref": [] }, "mpw_IncomeTaxesTable": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "IncomeTaxesTable", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes [Table]", "label": "Income Taxes [Table]", "documentation": "Income Taxes [Table]" } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]", "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure" } } }, "auth_ref": [ "r735", "r746", "r756", "r781" ] }, "mpw_SyndicatedTermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "SyndicatedTermLoanMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Syndicated Term Loan [Member]", "label": "Syndicated Term Loan [Member]", "documentation": "Syndicated term loan." } } }, "auth_ref": [] }, "mpw_PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of dividends which could be paid from adjusted operating funds", "label": "Percentage Of Dividends Payable On Basis Of Adjusted Operating Funds", "documentation": "Percentage of dividends payable on basis of adjusted operating funds." } } }, "auth_ref": [] }, "mpw_OtherFinancingLeasesNetOfAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "OtherFinancingLeasesNetOfAllowanceForCreditLoss", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "parentTag": "us-gaap_NetInvestmentInLease", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Other financing leases (net of allowance for credit loss)", "label": "Other Financing Leases Net Of Allowance For Credit Loss", "documentation": "Other financing leases, net of allowance for credit loss." } } }, "auth_ref": [] }, "mpw_DebtRefinancingAndUnutilizedFinancingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "DebtRefinancingAndUnutilizedFinancingCosts", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Debt refinancing and unutilized financing (benefit) costs", "negatedLabel": "Debt refinancing and unutilized financing benefit (costs)", "label": "Debt Refinancing And Unutilized Financing Costs", "documentation": "Debt refinancing and unutilized financing costs." } } }, "auth_ref": [] }, "mpw_DevelopmentProjectsEstimatedRentCommencementDate": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "DevelopmentProjectsEstimatedRentCommencementDate", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated Rent Commencement Date", "label": "Development Projects Estimated Rent Commencement Date", "documentation": "Development projects estimated rent commencement date." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupNotDiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupNotDiscontinuedOperationsMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Not Discontinued Operations [Member]", "documentation": "Disposal group that is not classified as discontinued operations." } } }, "auth_ref": [] }, "mpw_EquityMethodInvestmentAndOtherLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "EquityMethodInvestmentAndOtherLoansMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Method Investment and Other Loans [Member]", "label": "Equity Method Investment And Other Loans [Member]", "documentation": "Equity method investment and other loans.", "verboseLabel": "Investments in Unconsolidated Operating Entities [Member]" } } }, "auth_ref": [] }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainsLossesOnExtinguishmentOfDebt", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain on perpayment of Debt", "label": "Gain (Loss) on Extinguishment of Debt", "totalLabel": "Gain (Loss) on Extinguishment of Debt, Total", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity." } } }, "auth_ref": [ "r10", "r55", "r56" ] }, "mpw_PurchaseOfNonControllingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PurchaseOfNonControllingInterest", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition of non-controlling interest", "label": "Purchase Of Non Controlling Interest", "documentation": "Purchase of non controlling interest." } } }, "auth_ref": [] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Controlling Interests [Member]", "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r66", "r368", "r839", "r840", "r841", "r892" ] }, "mpw_PercentageOfVacantOnLeasedProperty": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PercentageOfVacantOnLeasedProperty", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vacant on leased property.", "label": "Percentage Of Vacant On Leased Property", "terseLabel": "Percentage of vacant on leased property" } } }, "auth_ref": [] }, "mpw_TermLoanReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "TermLoanReceivable", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Term loan", "label": "Term Loan Receivable", "documentation": "Term loan receivable." } } }, "auth_ref": [] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "auth_ref": [ "r737", "r748", "r758", "r783" ] }, "mpw_PercentageOfLeasedAssetsOwned": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PercentageOfLeasedAssetsOwned", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Percentage of leased assets owned.", "label": "Percentage of Leased Assets Owned", "terseLabel": "Percentage of leased assets owned" } } }, "auth_ref": [] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "auth_ref": [ "r735", "r746", "r756", "r781" ] }, "mpw_UndistributedEarningAllocatedToParticipatingSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "UndistributedEarningAllocatedToParticipatingSecurities", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail": { "parentTag": "mpw_NetIncomeLessParticipatingSecuritiesShareInEarnings", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail" ], "lang": { "en-us": { "role": { "negatedLabel": "Participating securities\u2019 share in earnings", "label": "Undistributed Earning Allocated To Participating Securities", "documentation": "Undistributed earning allocated to participating securities." } } }, "auth_ref": [] }, "mpw_ImedHospitalesThreeFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "ImedHospitalesThreeFacilityMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "documentation": "IMED hospitales Three facility.", "label": "IMED Hospitales Three Facility [Member]", "terseLabel": "IMED [Member]" } } }, "auth_ref": [] }, "mpw_DevelopmentProjectsOriginalCommitmentAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "DevelopmentProjectsOriginalCommitmentAmount", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Commitment", "label": "Development Projects Original Commitment Amount", "documentation": "Development projects original commitment amount.", "verboseLabel": "Total commitment" } } }, "auth_ref": [] }, "mpw_FivePointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySevenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "FivePointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySevenMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Five Point Zero Zero Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Seven [Member]", "documentation": "Five point zero zero zero percentage senior unsecured notes due two thousand twenty seven.", "terseLabel": "5.000% Senior Unsecured Notes due 2027 [Member]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "totalLabel": "Total Equity / Capital", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r66", "r67", "r81", "r184", "r185", "r204", "r224", "r225", "r226", "r228", "r234", "r310", "r311", "r368", "r411", "r412", "r413", "r419", "r420", "r436", "r437", "r438", "r439", "r440", "r441", "r443", "r459", "r460", "r464", "r475", "r561", "r562", "r573", "r599", "r615", "r637", "r638", "r670", "r728", "r836", "r851", "r867", "r892" ] }, "mpw_IncreaseDecreaseInInterestAndRentReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "IncreaseDecreaseInInterestAndRentReceivable", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 18.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Interest and rent receivables", "negatedLabel": "Interest and rent receivables", "label": "Increase Decrease In Interest And Rent Receivable", "documentation": "Increase decrease in interest and rent receivable." } } }, "auth_ref": [] }, "us-gaap_ImpairmentOfRealEstate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfRealEstate", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Impairment of Real Estate", "terseLabel": "Net impairment charge", "documentation": "The charge against earnings in the period to reduce the carrying amount of real property to fair value." } } }, "auth_ref": [ "r833", "r853" ] }, "mpw_CircleHealthMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "CircleHealthMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Circle [Member]", "label": "Circle Health [Member]", "documentation": "Circle Health Group." } } }, "auth_ref": [] }, "mpw_TermLoanOnSaleOfTranchePrepay": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "TermLoanOnSaleOfTranchePrepay", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Term loan on sale of tranche prepay.", "label": "Term Loan on Sale of Tranche Prepay", "terseLabel": "Term loan" } } }, "auth_ref": [] }, "mpw_CommitmentAndContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "CommitmentAndContingenciesTable", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Commitment And Contingencies [Table]", "label": "Commitment And Contingencies [Table]", "documentation": "Commitment And Contingencies [Table]" } } }, "auth_ref": [] }, "mpw_AllOtherCountriesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "AllOtherCountriesMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "All other countries.", "label": "All Other Countries [Member]", "terseLabel": "All Other Countries [Member]" } } }, "auth_ref": [] }, "mpw_RentalRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "RentalRevenue", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rental revenue", "label": "Rental Revenue", "documentation": "Rental Revenue." } } }, "auth_ref": [] }, "mpw_TermLoanDueTwoThousandTwentyFourMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "TermLoanDueTwoThousandTwentyFourMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "lang": { "en-us": { "role": { "documentation": "Term loan due two thousand twenty four.", "label": "Term Loan Due Two Thousand Twenty Four [Member]", "terseLabel": "Term loan due 2024" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r738", "r749", "r759", "r784" ] }, "mpw_RepaymentsOfMortgageLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "RepaymentsOfMortgageLoan", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Repayments of mortgage loan.", "label": "Repayments Of Mortgage Loan", "terseLabel": "Repayments of mortgage loan" } } }, "auth_ref": [] }, "mpw_MortgagesAndOtherLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "MortgagesAndOtherLoansMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "documentation": "Mortgages and other loans.", "label": "Mortgages and Other Loans [Member]", "terseLabel": "Mortgage and Other Loans [Member]" } } }, "auth_ref": [] }, "mpw_Loans": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "Loans", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Loans, Book value", "label": "Loans", "documentation": "Loans." } } }, "auth_ref": [] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r738", "r749", "r759", "r784" ] }, "mpw_VariableInterestEntityEquityInvestmentsMaximumLossExposureAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "VariableInterestEntityEquityInvestmentsMaximumLossExposureAmount", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "documentation": "Variable interest entity equity investments maximum loss exposure amount.", "label": "Variable Interest Entity Equity Investments Maximum Loss Exposure Amount", "terseLabel": "Equity Investments" } } }, "auth_ref": [] }, "mpw_NumberOfFinancingLeases": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "NumberOfFinancingLeases", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Number of financing leases", "label": "Number Of Financing Leases", "documentation": "Number of financing leases." } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r799" ] }, "stpr_AZ": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "AZ", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "ARIZONA", "terseLabel": "Arizona [Member]" } } }, "auth_ref": [] }, "stpr_CA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "CA", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stockton, California [Member]", "label": "CALIFORNIA", "verboseLabel": "California [Member]" } } }, "auth_ref": [] }, "us-gaap_NonUsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonUsMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "Non-US [Member]", "terseLabel": "Total International [Member]", "documentation": "Countries excluding the United States of America (US)." } } }, "auth_ref": [ "r894", "r895", "r896", "r898" ] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving Credit Facility [Member]", "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "auth_ref": [ "r798" ] }, "mpw_LifepointBehavioralMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "LifepointBehavioralMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Lifepoint behavioral.", "label": "Lifepoint Behavioral [Member]", "terseLabel": "Lifepoint Behavioral [Member]" } } }, "auth_ref": [] }, "stpr_CT": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "CT", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Connecticut [Member]", "label": "CONNECTICUT" } } }, "auth_ref": [] }, "mpw_RealEstateAndOtherImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "RealEstateAndOtherImpairmentCharges", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 2.0 }, "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails": { "parentTag": "mpw_GainLossOnDispositionOfRealEstate", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Real estate and other impairment charges (recovery)", "negatedLabel": "Real estate and other impairment (charges) recovery", "documentation": "Real estate and other impairment charges.", "label": "Real Estate And Other Impairment Charges" } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance", "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance", "totalLabel": "Retained Earnings (Accumulated Deficit), Total", "terseLabel": "Distributions in excess of net income", "label": "Retained Earnings (Accumulated Deficit)", "verboseLabel": "Retained (deficit) earnings", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r105", "r132", "r545", "r563", "r565", "r571", "r598", "r715" ] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility", "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "auth_ref": [ "r798" ] }, "stpr_FL": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "FL", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Florida [Member]", "label": "FLORIDA" } } }, "auth_ref": [] }, "mpw_IntangibleLeaseAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "IntangibleLeaseAssetsMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Intangible Lease Assets [Member]", "documentation": "Intangible Lease Assets", "terseLabel": "Intangible Lease Assets [Member]", "verboseLabel": "Intangible Lease Assets" } } }, "auth_ref": [] }, "mpw_ImedHospitalesTwoFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "ImedHospitalesTwoFacilitiesMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "documentation": "IMED Hospitales Two Facilities.", "label": "IMED Hospitales Two Facilities [Member]", "terseLabel": "IMED [Member]" } } }, "auth_ref": [] }, "mpw_MassachusettsBasedGeneralAcuteCareHospitalsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "MassachusettsBasedGeneralAcuteCareHospitalsMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Massachusetts-based General Acute Care Hospitals [Member]", "label": "Massachusetts Based General Acute Care Hospitals [Member]", "documentation": "Massachusetts based general acute care hospitals." } } }, "auth_ref": [] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "auth_ref": [ "r803" ] }, "mpw_UnfavorableNonCashFairValueAdjustmentOnInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "UnfavorableNonCashFairValueAdjustmentOnInvestment", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Unfavorable non-cash fair value adjustment on investment", "label": "Unfavorable Non Cash Fair Value Adjustment On Investment", "documentation": "Unfavorable non-cash fair value adjustment on investment." } } }, "auth_ref": [] }, "us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PartnerTypeOfPartnersCapitalAccountNameDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Partner Type of Partners' Capital Account, Name", "label": "Partner Type of Partners' Capital Account, Name [Domain]", "documentation": "Capital accounts of each type or class of partner. Examples of classes of partners include, but are not limited to, general partners, limited partners, preferred partners, and other ownership interests." } } }, "auth_ref": [ "r133", "r576" ] }, "mpw_GrossInvestmentInRealEstateAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "GrossInvestmentInRealEstateAssets", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "mpw_NetInvestmentInRealEstateAssets", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Gross investment in real estate assets", "label": "Gross Investment In Real Estate Assets", "documentation": "Gross investment in real estate assets" } } }, "auth_ref": [] }, "mpw_TermLoanDueTwoThousandTwentyFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "TermLoanDueTwoThousandTwentyFiveMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "lang": { "en-us": { "role": { "documentation": "Term loan due two thousand twenty five.", "label": "Term Loan Due Two Thousand Twenty Five [Member]", "terseLabel": "Term loan due 2025" } } }, "auth_ref": [] }, "mpw_LongTermAcuteCareHospitalMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "LongTermAcuteCareHospitalMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long Term Acute Care Hospital [Member]", "label": "Long-term Acute Care Hospital [Member]", "documentation": "Long-term acute care hospital." } } }, "auth_ref": [] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r799" ] }, "mpw_RealEstateAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "RealEstateAssetsAbstract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Real estate assets", "label": "Real Estate Assets [Abstract]", "documentation": "Real Estate Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r313", "r314", "r319", "r320", "r321", "r322", "r323", "r324", "r362", "r367", "r442", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r553", "r697", "r813", "r814", "r815", "r816", "r817", "r818", "r819", "r847", "r848", "r849", "r850" ] }, "mpw_InternationalJointVentureMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "InternationalJointVentureMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "International Joint Venture [Member]", "label": "International Joint Venture [Member]", "documentation": "International joint venture." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility", "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "mpw_RevenueForRentAndInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "RevenueForRentAndInterest", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Revenue for rent and interest.", "label": "Revenue For Rent and Interest", "terseLabel": "Revenue for rent and interest" } } }, "auth_ref": [] }, "mpw_StockIssuedDuringPeriodValueStockVestingAndAmortizationOfStockBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "StockIssuedDuringPeriodValueStockVestingAndAmortizationOfStockBasedCompensation", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "terseLabel": "Stock (Unit) vesting and amortization of stock (unit)-based compensation", "label": "Stock Issued During Period Value Stock Vesting And Amortization Of Stock Based Compensation", "documentation": "Stock issued during period value stock vesting and amortization of stock based compensation." } } }, "auth_ref": [] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r799" ] }, "stpr_MA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "MA", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "MASSACHUSETTS", "terseLabel": "Massachusetts [Member]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss)", "terseLabel": "Net Income (Loss)", "totalLabel": "Net income attributable to MPT common stockholders (Operating Partnership partners)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r112", "r123", "r150", "r187", "r199", "r201", "r205", "r218", "r227", "r229", "r230", "r231", "r232", "r235", "r236", "r246", "r256", "r264", "r268", "r270", "r309", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r445", "r453", "r552", "r617", "r634", "r635", "r695", "r727", "r857" ] }, "mpw_LifepointBehavioralHealthMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "LifepointBehavioralHealthMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "documentation": "Lifepoint behavioral health.", "label": "Lifepoint Behavioral Health [Member]", "terseLabel": "Lifepoint Behavioral Health [Member]" } } }, "auth_ref": [] }, "mpw_AcquisitionLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "AcquisitionLoanMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Acquisition Loans [Member]", "label": "Acquisition Loan [Member]", "documentation": "Acquisition loan." } } }, "auth_ref": [] }, "us-gaap_InvestmentIncomeDividend": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeDividend", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Investment Income, Dividend", "terseLabel": "Dividend income", "documentation": "Amount of dividend income on nonoperating securities." } } }, "auth_ref": [ "r116" ] }, "mpw_StockIssuedDuringPeriodValueStockVestingSatisfactionOfTaxWithholdingShares": { "xbrltype": "sharesItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "StockIssuedDuringPeriodValueStockVestingSatisfactionOfTaxWithholdingShares", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "negatedLabel": "Stock vesting - satisfaction of tax withholding (Shares)", "terseLabel": "Stock vesting - satisfaction of tax withholding (Shares)", "label": "Stock Issued During Period Value Stock Vesting Satisfaction Of Tax Withholding Shares", "documentation": "Stock Issued During Period Value Stock Vesting Satisfaction Of Tax Withholding shares" } } }, "auth_ref": [] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r799" ] }, "mpw_PropertyRelatedExpensesAndWriteOffStraightLineRent": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PropertyRelatedExpensesAndWriteOffStraightLineRent", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails": { "parentTag": "mpw_GainLossOnDispositionOfRealEstate", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property-related expenses", "label": "Property-related Expenses and Write-off Straight Line Rent", "documentation": "Property-related Expenses and Write-off Straight Line Rent" } } }, "auth_ref": [] }, "mpw_NumberOfLeasedFacilities": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "NumberOfLeasedFacilities", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of leased facilities.", "label": "Number Of Leased Facilities", "terseLabel": "Number of leased facilities" } } }, "auth_ref": [] }, "us-gaap_OtherAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "Other Assets [Member]", "terseLabel": "Other Assets [Member]", "documentation": "Primary financial statement caption encompassing other assets." } } }, "auth_ref": [ "r84", "r87" ] }, "mpw_ThreePointThreeTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "ThreePointThreeTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyFiveMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Three Point Three Two Five Percentage Senior Unsecured Notes Due Two Thousand Twenty Five [Member]", "documentation": "Three point three two five percentage senior unsecured notes due two thousand twenty five.", "terseLabel": "3.325% Senior Unsecured Notes due 2025 [Member]" } } }, "auth_ref": [] }, "us-gaap_NetInvestmentInLease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetInvestmentInLease", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "mpw_GrossInvestmentInRealEstateAssets", "weight": 1.0, "order": 1.0 }, "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total investment in financing leases", "terseLabel": "Investment in financing leases", "label": "Net Investment in Lease, before Allowance for Credit Loss", "documentation": "Amount, before allowance for credit loss, of net investment in sales-type and direct financing leases." } } }, "auth_ref": [ "r166", "r319", "r469", "r852" ] }, "mpw_UnbilledRentAccruals": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "UnbilledRentAccruals", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Unbilled rent accruals.", "label": "Unbilled Rent Accruals", "terseLabel": "Unbilled rent accruals" } } }, "auth_ref": [] }, "mpw_DirectFinancingLeaseUnearnedIncomeAndAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "DirectFinancingLeaseUnearnedIncomeAndAllowanceForCreditLoss", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "parentTag": "us-gaap_DirectFinancingLeaseNetInvestmentInLease", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Unearned income and allowance for credit loss", "label": "Direct Financing Lease Unearned Income And Allowance For Credit Loss", "documentation": "Direct financing lease, unearned income and allowance for credit loss." } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r224", "r225", "r226", "r255", "r516", "r569", "r577", "r589", "r591", "r592", "r593", "r594", "r595", "r597", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r610", "r611", "r612", "r613", "r614", "r616", "r618", "r619", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r636", "r721" ] }, "mpw_EstimatedConcentrationRiskPercentage": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "EstimatedConcentrationRiskPercentage", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated concentration risk", "label": "Estimated Concentration Risk Percentage", "documentation": "Estimated concentration risk percentage." } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r799" ] }, "mpw_PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Lease deposits and other obligations to tenants", "negatedLabel": "Lease deposits and other obligations to tenants", "label": "Payments For Proceeds From Lease Deposits And Other Obligations To Tenants", "documentation": "Payments for proceeds from lease deposits and other obligations to tenants." } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiability", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Contract with Customer, Liability, Total", "terseLabel": "Deferred revenue", "label": "Contract with Customer, Liability", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r369", "r370", "r371" ] }, "mpw_StewardMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "StewardMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Steward (Macquarie Transaction) [Member]", "documentation": "Steward.", "label": "Steward [Member]", "terseLabel": "Steward [Member]" } } }, "auth_ref": [] }, "mpw_GBPDenominatedBorrowingsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "GBPDenominatedBorrowingsMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "GBP-denominated Borrowings [Member]", "label": "G B P Denominated Borrowings [Member]", "documentation": "GBP-denominated Borrowings [Member]" } } }, "auth_ref": [] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "auth_ref": [ "r800" ] }, "mpw_FirstLienSecuredLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "FirstLienSecuredLoan", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "First lien secured loan.", "label": "First Lien Secured Loan", "terseLabel": "First lien secured loan" } } }, "auth_ref": [] }, "mpw_NumberOfPropertiesSold": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "NumberOfPropertiesSold", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Number of properties disposed", "terseLabel": "Number of properties sold", "label": "Number Of Properties Sold", "documentation": "Number of properties sold." } } }, "auth_ref": [] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r770" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "stpr_OH": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "OH", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ohio [Member]", "label": "OHIO" } } }, "auth_ref": [] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r800" ] }, "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MortgageLoansOnRealEstateCommercialAndConsumerNet", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "mpw_GrossInvestmentInRealEstateAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Mortgage Loans on Real Estate, Commercial and Consumer, Net, Total", "terseLabel": "Mortgage loans", "label": "Mortgage Loans on Real Estate, Commercial and Consumer, Net", "documentation": "The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio." } } }, "auth_ref": [ "r537" ] }, "mpw_ProspectMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "ProspectMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Prospect.", "label": "Prospect [Member]", "terseLabel": "Prospect [Member]" } } }, "auth_ref": [] }, "mpw_NonrecourseSecuredDebtPercentageOfAssetValue": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "NonrecourseSecuredDebtPercentageOfAssetValue", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Nonrecourse secured debt percentage of asset value", "label": "Nonrecourse Secured Debt Percentage Of Asset Value", "documentation": "Nonrecourse secured debt percentage of asset value." } } }, "auth_ref": [] }, "mpw_OtherTenantUpdatesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "OtherTenantUpdatesMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherTenantUpdatesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Other Tenant Updates [Member]", "documentation": "Other tenant updates." } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss", "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r30", "r31", "r109", "r191", "r544", "r564", "r565" ] }, "mpw_AlectoHealthcareServicesLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "AlectoHealthcareServicesLlcMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Alecto healthcare services llc.", "label": "Alecto Healthcare Services LLC [Member]", "terseLabel": "Alecto Healthcare Services LLC [Member]" } } }, "auth_ref": [] }, "stpr_PA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "PA", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "PENNSYLVANIA", "terseLabel": "Pennsylvania [Member]" } } }, "auth_ref": [] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "auth_ref": [ "r801" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "periodEndLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance", "periodStartLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Beginning Balance", "totalLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Total", "terseLabel": "Non-controlling interests", "label": "Equity, Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r29", "r145", "r218", "r309", "r337", "r339", "r340", "r341", "r344", "r345", "r453", "r546", "r599" ] }, "mpw_ProceedsToPaydownOfActualOutstandingLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "ProceedsToPaydownOfActualOutstandingLoan", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Proceeds to paydown of actual outstanding loan.", "label": "Proceeds To Paydown Of Actual Outstanding Loan", "terseLabel": "Proceeds to paydown of actual outstanding loan" } } }, "auth_ref": [] }, "mpw_PercentageOfAssetsAgreedToSell": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PercentageOfAssetsAgreedToSell", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherTenantUpdatesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of total asstes held for sale", "label": "Percentage Of Assets Agreed To Sell", "documentation": "Percentage of assets agreed to sell." } } }, "auth_ref": [] }, "mpw_MaximumPercentageOfEntitysAssetsInvestedOnSingleProperty": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "MaximumPercentageOfEntitysAssetsInvestedOnSingleProperty", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum percentage of entity's assets invested on single property", "label": "Maximum Percentage Of Entitys Assets Invested On Single Property", "documentation": "Maximum percentage of entity's assets invested on single property." } } }, "auth_ref": [] }, "mpw_WaterlandPrivateEquityFundVIICVMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "WaterlandPrivateEquityFundVIICVMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Waterland Private Equity Fund VII C.V. [Member]", "terseLabel": "Waterland Private Equity Fund VII C.V. [Member]", "label": "Waterland Private Equity Fund V I I C V [Member]", "documentation": "Waterland Private Equity Fund VII C.V." } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location", "label": "Balance Sheet Location [Domain]", "documentation": "Location in the balance sheet (statement of financial position)." } } }, "auth_ref": [ "r84", "r85" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "auth_ref": [ "r800" ] }, "mpw_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesNetOfTax", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "verboseLabel": "Unrealized gain (loss) on interest rate swap, net of tax", "terseLabel": "Unrealized (loss) gain on interest rate swaps, net of tax", "label": "Other Comprehensive Income Unrealized Gain Loss On Derivatives Net Of Tax", "documentation": "Other comprehensive income unrealized gain (loss) on derivatives net of tax." } } }, "auth_ref": [] }, "mpw_BusinessCombinationLoansPaidDownOnAcquisitionLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "BusinessCombinationLoansPaidDownOnAcquisitionLoans", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Loans repaid", "negatedLabel": "Loans repaid", "verboseLabel": "Advanced to the mortgage loan", "label": "Business Combination Loans Paid Down On Acquisition Loans", "documentation": "Business combination loans paid down on acquisition loans." } } }, "auth_ref": [] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "auth_ref": [ "r802" ] }, "mpw_LoansOneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "LoansOneMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "documentation": "Loans one.", "label": "Loans One [Member]", "terseLabel": "Loans, Net One [Member]" } } }, "auth_ref": [] }, "mpw_EquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "EquityIncentivePlanMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Incentive Plan [Member]", "label": "Equity Incentive Plan [Member]", "documentation": "Equity incentive plan member." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "auth_ref": [ "r801" ] }, "mpw_NumberOfLeasedProperties": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "NumberOfLeasedProperties", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of leased properties", "label": "Number Of Leased Properties", "documentation": "Number of leased properties." } } }, "auth_ref": [] }, "us-gaap_PledgingPurposeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PledgingPurposeAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "label": "Pledging Purpose [Axis]", "documentation": "Information by pledging purpose of pledged asset owned." } } }, "auth_ref": [ "r496", "r712", "r716", "r810" ] }, "mpw_PhpHoldingsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PhpHoldingsMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDlomBySensitivityAnalysisByUsingBasisPointVariationsDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "PHP Holdings [Member]", "label": "PHP Holdings [Member]" } } }, "auth_ref": [] }, "mpw_ErnestHealthIncMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "ErnestHealthIncMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Ernest [Member]", "verboseLabel": "Ernest Health Inc [Member]", "label": "Ernest Health Inc [Member]", "documentation": "Ernest Health, Inc." } } }, "auth_ref": [] }, "mpw_LesseeOperatingLeaseInitialFixedTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "LesseeOperatingLeaseInitialFixedTermOfContract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Lease extension expiration term", "label": "Lessee Operating Lease Initial Fixed Term Of Contract", "documentation": "Lessee operating lease initial fixed term of contract." } } }, "auth_ref": [] }, "us-gaap_PledgingPurposeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PledgingPurposeDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "label": "Pledging Purpose [Domain]", "documentation": "Pledging purpose of pledged asset owned." } } }, "auth_ref": [ "r496", "r712", "r716", "r810" ] }, "mpw_InvestmentsInOtherLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "InvestmentsInOtherLoans", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Other loans", "label": "Investments in Other Loans", "documentation": "Investments in other loans." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDlomBySensitivityAnalysisByUsingBasisPointVariationsDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition", "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r62", "r63", "r426", "r707", "r708" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Earnings Per Share Basic By Common Class [Table]", "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]", "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share." } } }, "auth_ref": [ "r40", "r41", "r241", "r245", "r247" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureOrganization" ], "lang": { "en-us": { "role": { "terseLabel": "Organization", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r98", "r134", "r567", "r568" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Domain]", "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "mpw_NumberOfFacilitiesAcquired": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "NumberOfFacilitiesAcquired", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of facilities acquired,", "label": "Number Of Facilities Acquired", "terseLabel": "Number of facilities acquired" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDlomBySensitivityAnalysisByUsingBasisPointVariationsDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Acquiree", "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r426", "r707", "r708" ] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Dividends (Distributions) declared per common share / unit", "terseLabel": "Dividends declared per common share (unit)", "label": "Common Stock, Dividends, Per Share, Declared", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r132" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "mpw_NoncashInvestingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "NoncashInvestingItemsAbstract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "documentation": "Noncash investing items.", "label": "Noncash Investing Items [Abstract]", "terseLabel": "Supplemental schedule of non-cash investing activities:" } } }, "auth_ref": [] }, "mpw_StewardHealthCareSystemLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "StewardHealthCareSystemLLCMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Steward [Member]", "terseLabel": "Steward Health Care System LLC [Member]", "label": "Steward Health Care System L L C [Member]", "documentation": "Steward Health Care System LLC." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesCoronavirusCovid19RentDeferralsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherTenantUpdatesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Business Acquisitions By Acquisition [Table]", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities." } } }, "auth_ref": [ "r62", "r63", "r426" ] }, "mpw_PositiveHundredBasisPointsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PositiveHundredBasisPointsMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDlomBySensitivityAnalysisByUsingBasisPointVariationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "+ 100 Basis Points [Member]", "label": "Positive Hundred Basis Points [Member]", "documentation": "Positive Hundred Basis Points." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesCoronavirusCovid19RentDeferralsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherTenantUpdatesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Line Items]", "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r426" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "mpw_LesseeOperatingLeaseExtendedExpirationYearOfContract": { "xbrltype": "gYearItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "LesseeOperatingLeaseExtendedExpirationYearOfContract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Lessee operating lease extended expiration year of contract.", "label": "Lessee Operating Lease Extended Expiration Year Of Contract", "terseLabel": "Lease extension expiration year" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency", "label": "Measurement Frequency [Domain]", "documentation": "Measurement frequency." } } }, "auth_ref": [] }, "mpw_MaximumPercentageOfUnencumberedAssets": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "MaximumPercentageOfUnencumberedAssets", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum percentage of total unencumbered assets", "label": "Maximum Percentage Of Unencumbered Assets", "documentation": "Maximum percentage of unencumbered assets." } } }, "auth_ref": [] }, "mpw_CommonUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "CommonUnitsMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common Units", "label": "Common Units [Member]", "documentation": "Common units." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Percentage of concentration risk", "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r43", "r46", "r90", "r91", "r274" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r224", "r225", "r226", "r255", "r516", "r569", "r577", "r589", "r591", "r592", "r593", "r594", "r595", "r597", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r610", "r611", "r612", "r613", "r614", "r616", "r618", "r619", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r636", "r721" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureStockAwards" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Awards", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r376", "r380", "r407", "r408", "r410", "r710" ] }, "mpw_FundingOfRedevelopmentRecoveryReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "FundingOfRedevelopmentRecoveryReceivables", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Funding of redevelopment recovery receivables.", "label": "Funding of Redevelopment Recovery Receivables", "documentation": "Funding of redevelopment recovery receivables." } } }, "auth_ref": [] }, "mpw_ThreePointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandThirtyOneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "ThreePointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandThirtyOneMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "3.500% Senior Unsecured Notes due 2031 [Member]", "label": "Three Point Five Zero Zero Percentage Senior Unsecured Notes Due Two Thousand Thirty One [Member]", "documentation": "Three point five zero zero percentage senior unsecured notes due two thousand thirty one." } } }, "auth_ref": [] }, "us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DirectFinancingLeaseLeaseIncomeTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Components of Total Investment in Financing Leases", "label": "Direct Financing Lease, Lease Income [Table Text Block]", "documentation": "Tabular disclosure of components of lease income from direct financing lease." } } }, "auth_ref": [ "r254", "r471" ] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r362", "r367", "r442", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r553", "r813", "r814", "r815", "r816", "r817", "r818", "r819", "r847", "r848", "r849", "r850" ] }, "mpw_ImedHospitalesOneFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "ImedHospitalesOneFacilityMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "documentation": "IMED Hospitales One Facility.", "label": "IMED Hospitales One Facility [Member]", "terseLabel": "IMED [Member]" } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "mpw_InterestAndRentReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "InterestAndRentReceivable", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Interest and rent receivables, Book value", "label": "Interest And Rent Receivable", "documentation": "Interest and rent receivable.", "terseLabel": "Interest and rent receivables, net" } } }, "auth_ref": [] }, "mpw_DebtInstrumentPurchaseYieldPercentage": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "DebtInstrumentPurchaseYieldPercentage", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase yield average percentage", "label": "Debt Instrument Purchase Yield Percentage", "documentation": "Debt instrument purchase yield percentage." } } }, "auth_ref": [] }, "us-gaap_MajorPropertyClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MajorPropertyClassAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Major Property Class", "label": "Major Property Class [Axis]", "documentation": "Amount of property owned but leased or available for lease to third parties, by major property class." } } }, "auth_ref": [ "r161" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r731" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r731" ] }, "us-gaap_MajorPropertyClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MajorPropertyClassDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Major Property Class", "label": "Major Property Class [Domain]", "documentation": "The major classes of assets leased or available for lease to third parties under operating lease agreements as of the balance sheet date." } } }, "auth_ref": [ "r161" ] }, "mpw_AevisVictoriaSAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "AevisVictoriaSAMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aevis Victoria SA [Member]", "label": "Aevis Victoria S A [Member]", "documentation": "Aevis Victoria SA." } } }, "auth_ref": [] }, "mpw_ProspectMedicalHoldingsIncMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "ProspectMedicalHoldingsIncMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Prospect [Member]", "label": "Prospect Medical Holdings Inc [Member]", "documentation": "Prospect Medical Holdings Inc." } } }, "auth_ref": [] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r731" ] }, "us-gaap_DirectFinancingLeaseNetInvestmentInLease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DirectFinancingLeaseNetInvestmentInLease", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "parentTag": "us-gaap_NetInvestmentInLease", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Net investment in direct financing leases", "label": "Direct Financing Lease, Net Investment in Lease, before Allowance for Credit Loss", "documentation": "Amount, before allowance for credit loss, of net investment in direct financing lease." } } }, "auth_ref": [ "r166", "r319", "r473", "r852" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "terseLabel": "Award Type", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income:", "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "mpw_CommitmentAndContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "CommitmentAndContingenciesLineItems", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Commitment And Contingencies [Line Items]", "label": "Commitment And Contingencies [Line Items]", "documentation": "Commitment And Contingencies [Line Items]" } } }, "auth_ref": [] }, "mpw_StraightLineRentRevenueNetOfWriteOffs": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "StraightLineRentRevenueNetOfWriteOffs", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Straight-line rent", "label": "Straight Line Rent Revenue Net Of Write Offs", "documentation": "Straight line rent revenue net of write offs." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r731" ] }, "mpw_StraightLineRentWriteOffs": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "StraightLineRentWriteOffs", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "straight-Line Rent Write-Offs", "documentation": "straight-line rent write-offs.", "terseLabel": "Straight-line rent write-offs" } } }, "auth_ref": [] }, "us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DirectFinancingLeaseUnguaranteedResidualAsset", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "parentTag": "us-gaap_DirectFinancingLeaseNetInvestmentInLease", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated unguaranteed residual values", "label": "Direct Financing Lease, Unguaranteed Residual Asset", "documentation": "Present value expected to be derived from underlying asset, following end of lease term, not guaranteed by lessee or other third party unrelated to lessor." } } }, "auth_ref": [ "r473" ] }, "us-gaap_CostsAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpensesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Expenses", "label": "Costs and Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income attributable to MPT common stockholders (Operating Partnership Partners)", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r32", "r200", "r202", "r210", "r534", "r556" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r128", "r331", "r332", "r673", "r855" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Significant Accounting Policies", "label": "Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r124", "r217" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LoansMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LoansMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Loans [Member]", "documentation": "When a lender gives money or property over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors." } } }, "auth_ref": [ "r48", "r692" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type", "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r43", "r46", "r90", "r91", "r274", "r672", "r812" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Accounts Payable and Accrued Liabilities, Total", "terseLabel": "Accounts payable and accrued expenses", "label": "Accounts Payable and Accrued Liabilities", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations." } } }, "auth_ref": [ "r96" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "us-gaap_DirectFinancingLeaseNetInvestmentInLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DirectFinancingLeaseNetInvestmentInLeasesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Direct Financing Lease Net Investment In Leases [Abstract]", "label": "Direct Financing Lease, Net Investment in Lease, before Allowance for Credit Loss [Abstract]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "us-gaap_NumberOfCountriesInWhichEntityOperates": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfCountriesInWhichEntityOperates", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Number of countries", "label": "Number of Countries in which Entity Operates", "documentation": "The number of countries in which the entity operates as of balance sheet date." } } }, "auth_ref": [] }, "us-gaap_RealEstateAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateAbstract", "lang": { "en-us": { "role": { "label": "Real Estate [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Incremental Common Shares Attributable to Share-based Payment Arrangements, Total", "terseLabel": "Dilutive potential common shares", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r242", "r243", "r244", "r249", "r379" ] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CounterpartyNameAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution." } } }, "auth_ref": [ "r183", "r221", "r222", "r349", "r366", "r478", "r688", "r690" ] }, "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfLinesOfCredit", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Proceeds from (Repayments of) Lines of Credit, Total", "label": "Proceeds from (Repayments of) Lines of Credit", "terseLabel": "Revolving credit facility, net", "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets)." } } }, "auth_ref": [] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "periodEndLabel": "Preferred Stock, Value, Issued, Ending Balance", "periodStartLabel": "Preferred Stock, Value, Issued, Beginning Balance", "totalLabel": "Preferred Stock, Value, Issued, Total", "terseLabel": "Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r102", "r542", "r715" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "us-gaap_RealEstateHeldforsale": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateHeldforsale", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "mpw_GrossInvestmentInRealEstateAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Real estate held for sale", "label": "Real Estate, Held-for-Sale", "documentation": "Amount of investment in land and building held for sale. Excludes real estate considered inventory." } } }, "auth_ref": [ "r883" ] }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Dividends Payable", "terseLabel": "Dividends declared, unpaid", "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding." } } }, "auth_ref": [ "r100", "r101", "r143", "r726", "r884" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "totalLabel": "Common Stock, Shares, Issued, Total", "terseLabel": "Common stock, shares issued", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r103" ] }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PriorPeriodReclassificationAdjustmentDescription", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassifications", "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r824" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r103", "r597" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance", "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance", "terseLabel": "Common stock, shares outstanding", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r19", "r103", "r597", "r615", "r892", "r893" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "us-gaap_AssetBackedSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetBackedSecuritiesMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Backed Credit Facility [Member]", "label": "Asset-Backed Securities [Member]", "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans." } } }, "auth_ref": [ "r706", "r844", "r845", "r846" ] }, "us-gaap_LongTermDebtTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebt" ], "lang": { "en-us": { "role": { "terseLabel": "Debt", "label": "Long-Term Debt [Text Block]", "documentation": "The entire disclosure for long-term debt." } } }, "auth_ref": [ "r129" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Unaudited Interim Condensed Consolidated Financial Statements", "label": "Consolidation, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r69", "r691" ] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r373", "r476", "r477", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r591", "r592", "r593", "r594", "r595", "r614", "r616", "r639", "r871" ] }, "us-gaap_LoansHeldForSaleFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LoansHeldForSaleFairValueDisclosure", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Loans, Fair value", "label": "Loan, Held-for-Sale, Fair Value Disclosure", "documentation": "Fair value portion of loans held-for-sale including, but not limited to, mortgage loans and finance receivables." } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r26" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used for financing activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r215" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Total net assets acquired", "terseLabel": "Total net assets acquired", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed." } } }, "auth_ref": [ "r64", "r65" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Financing activities", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingAssets", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 19.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Increase (Decrease) in Other Operating Assets, Total", "negatedLabel": "Other assets", "label": "Increase (Decrease) in Other Operating Assets", "documentation": "Amount of increase (decrease) in operating assets classified as other." } } }, "auth_ref": [ "r9" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by investing activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r215" ] }, "us-gaap_NumberOfBusinessesAcquired": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfBusinessesAcquired", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Number of facilities acquired", "label": "Number of Businesses Acquired", "documentation": "The number of businesses acquired by the entity during the period." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Investing activities", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r121", "r122", "r123" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r731" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Operating activities", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 0.0 }, "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails": { "parentTag": "mpw_GainLossOnDispositionOfRealEstate", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total revenues", "label": "Revenues", "terseLabel": "Total Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r207", "r218", "r257", "r258", "r263", "r266", "r267", "r271", "r272", "r274", "r309", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r453", "r536", "r857" ] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnitTables" ], "lang": { "en-us": { "role": { "terseLabel": "Calculation of Earnings Per Share", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r843" ] }, "us-gaap_AssetsSoldUnderAgreementsToRepurchaseTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsSoldUnderAgreementsToRepurchaseTypeDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Assets Sold under Agreements to Repurchase, Type [Domain]", "documentation": "This is the type of such assets (for example, US Treasury Obligations, US Government agency obligations and loans, and so forth). This item may be presented as an element in the table that is disclosed when the carrying amount (or market value, if higher than the carrying amount) of securities or other assets sold under repurchase agreements exceed 10 percent of total assets, as of the most recent balance sheet date." } } }, "auth_ref": [ "r220" ] }, "us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsSoldUnderAgreementsToRepurchaseAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Securities or Other Assets Sold under Agreements to Repurchase [Axis]", "documentation": "Information by securities or other assets sold under repurchase agreements. Repurchase agreements are agreements under which the transferor (repo party) transfers a security to a transferee (repo counterparty or reverse party) in exchange for cash and concurrently agrees to reacquire that security at a future date for an amount equal to the cash exchanged plus a stipulated interest factor." } } }, "auth_ref": [ "r220" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type", "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r465", "r480" ] }, "us-gaap_GainsLossesOnSalesOfInvestmentRealEstate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainsLossesOnSalesOfInvestmentRealEstate", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 }, "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "(Loss) gain on sale of real estate", "label": "Gains (Losses) on Sales of Investment Real Estate", "negatedLabel": "Gain on sale of real estate", "documentation": "The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes." } } }, "auth_ref": [ "r163", "r164", "r165", "r828", "r829", "r833", "r882", "r891" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares authorized", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r102", "r597" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance", "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance", "terseLabel": "Preferred stock, shares outstanding", "label": "Preferred Stock, Shares Outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r102", "r597", "r615", "r892", "r893" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Income (loss) before income tax", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r110", "r149", "r256", "r264", "r268", "r270", "r536", "r549", "r695" ] }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfFinancingCostsAndDiscounts", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Amortization of Debt Issuance Costs and Discounts, Total", "terseLabel": "Amortization of deferred financing costs and debt discount", "label": "Amortization of Debt Issuance Costs and Discounts", "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs." } } }, "auth_ref": [ "r361", "r467", "r701", "r702", "r833" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "periodEndLabel": "Stockholders' Equity Attributable to Parent, Ending Balance", "periodStartLabel": "Stockholders' Equity Attributable to Parent, Beginning Balance", "totalLabel": "Total Medical Properties Trust, Inc. Stockholders' Equity (MPT Operating Partnership, L.P. capital)", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r103", "r106", "r107", "r125", "r599", "r615", "r637", "r638", "r715", "r729", "r836", "r851", "r867", "r892" ] }, "us-gaap_AssetsTotalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsTotalMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Total Assets", "terseLabel": "Total Gross Assets [Member]", "label": "Assets, Total [Member]", "documentation": "Total assets, when it serves as a benchmark in a concentration of risk calculation, representing the sum of all reported assets as of the balance sheet date." } } }, "auth_ref": [] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues", "label": "Revenues [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type", "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r465", "r480" ] }, "us-gaap_RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Investments in unconsolidated real estate joint ventures", "label": "Real Estate Investments, Unconsolidated Real Estate and Other Joint Ventures", "documentation": "The carrying amount of investments in unconsolidated real estate and other joint ventures not separately presented. This includes direct and indirect investments." } } }, "auth_ref": [ "r883" ] }, "us-gaap_InvestmentTypeCategorizationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTypeCategorizationMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Investments", "label": "Investments [Domain]", "documentation": "Asset obtained to generate income or appreciate in value." } } }, "auth_ref": [ "r579", "r581", "r582", "r584", "r586", "r640", "r642", "r648", "r652", "r654", "r657", "r658", "r664", "r666", "r667", "r668", "r669", "r720" ] }, "us-gaap_UnsecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnsecuredDebt", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Unsecured Debt, Total", "terseLabel": "Amount of senior unsecured debt", "label": "Unsecured Debt", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer)." } } }, "auth_ref": [ "r21", "r144", "r885" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ProvisionForLoanLeaseAndOtherLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForLoanLeaseAndOtherLosses", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesCreditLossReservesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Provision (recovery) for credit loss", "label": "Provision for Loan, Lease, and Other Losses", "totalLabel": "Provision for Loan, Lease, and Other Losses, Total", "documentation": "Amount of expense related loan transactions, lease transactions, credit loss from transactions other than loan and lease transactions, and other loss based on assessment of uncollectability from the counterparty to reduce the account to their net realizable value." } } }, "auth_ref": [ "r9", "r15", "r151" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Cost of Goods and Services Sold, Total", "label": "Cost of Goods and Services Sold", "terseLabel": "Costs Incurred as of June 30, 2023", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r114", "r516" ] }, "us-gaap_RestrictedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Restricted Cash and Cash Equivalents, Total", "periodStartLabel": "Restricted cash, included in Other assets at beginning of period", "periodEndLabel": "Restricted cash, included in Other assets at end of period", "label": "Restricted Cash and Cash Equivalents", "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r39", "r139", "r188", "r216", "r541" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Depreciation, Depletion and Amortization, Total", "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r10", "r260" ] }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance", "terseLabel": "Issuance of non-controlling interests", "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders." } } }, "auth_ref": [ "r17", "r59", "r136" ] }, "us-gaap_ProvisionForLoanLossesExpensed": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForLoanLossesExpensed", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfActivityInCreditLossReservesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Provision (recovery) for credit loss, net", "label": "Financing Receivable, Credit Loss, Expense (Reversal)", "documentation": "Amount of credit loss expense (reversal of expense) for financing receivable." } } }, "auth_ref": [ "r316", "r531" ] }, "us-gaap_UnusualRiskOrUncertaintyNatureDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnusualRiskOrUncertaintyNatureDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Unusual Risk or Uncertainty, Nature", "label": "Unusual Risk or Uncertainty, Nature [Domain]", "documentation": "Describes the nature of the unusual risk or uncertainty, such as the threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost." } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r23", "r218", "r309", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r430", "r433", "r434", "r453", "r596", "r694", "r729", "r857", "r872", "r873" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "periodStartLabel": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax, Beginning Balance", "periodEndLabel": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax, Ending Balance", "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax", "terseLabel": "Accumulated other comprehensive income (loss), foreign currency translation adjustment, net of tax", "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses." } } }, "auth_ref": [ "r193", "r194", "r195", "r196", "r452" ] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities", "label": "Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivablesAbstract", "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "mpw_ThreePointThreeSevenFivePercentageSeniorUnsecuredNotesDueTwoThousandThirtyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "ThreePointThreeSevenFivePercentageSeniorUnsecuredNotesDueTwoThousandThirtyMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "3.375% Senior Unsecured Notes due 2030 [Member]", "label": "Three Point Three Seven Five Percentage Senior Unsecured Notes Due Two Thousand Thirty [Member]", "documentation": "Three point three seven five percentage senior unsecured notes due two thousand thirty." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesCreditLossReservesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]", "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables." } } }, "auth_ref": [ "r28" ] }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Income (Loss) from Equity Method Investments, Total", "terseLabel": "Earnings from equity interests", "label": "Income (Loss) from Equity Method Investments", "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)." } } }, "auth_ref": [ "r10", "r111", "r148", "r261", "r305", "r548" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities and Equity / Capital", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r108", "r146", "r547", "r715", "r836", "r851", "r867" ] }, "us-gaap_UnusualRiskOrUncertaintyByNatureAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnusualRiskOrUncertaintyByNatureAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Unusual Risk or Uncertainty, Nature", "label": "Unusual Risk or Uncertainty, Nature [Axis]", "documentation": "Information by nature of risk and uncertainty, for example, but not limited to, threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost." } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities and Equity", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r325", "r326", "r327", "r328", "r517", "r518" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r50", "r51" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. [Member]", "label": "UNITED STATES", "verboseLabel": "Total U.S. [Member]" } } }, "auth_ref": [] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r740", "r751", "r761", "r786" ] }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByBalanceSheetGroupingTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Fair Value Information of Financial Instruments", "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]", "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r88", "r89" ] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Payment for acquisition", "label": "Payments to Acquire Businesses, Gross", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r35", "r427" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]", "terseLabel": "Insider Trading Policies and Procedures:" } } }, "auth_ref": [ "r734", "r804" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r770" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "auth_ref": [ "r743", "r754", "r764", "r789" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r805" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r741", "r752", "r762", "r787" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r734", "r804" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r742", "r753", "r763", "r788" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "auth_ref": [ "r742", "r753", "r763", "r780", "r788" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r734", "r804" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total", "terseLabel": "Cash and cash equivalents", "periodStartLabel": "Cash and cash equivalents at beginning of period", "periodEndLabel": "Cash and cash equivalents at end of period", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r39", "r188", "r687" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]", "terseLabel": "Award Timing Disclosures" } } }, "auth_ref": [ "r791" ] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstruments" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value of Financial Instruments", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r446" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r742", "r753", "r763", "r788" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r742", "r753", "r763", "r788" ] }, "us-gaap_LessorOperatingLeaseTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeaseTermOfContract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Initial fixed terms of lease", "label": "Lessor, Operating Lease, Term of Contract", "verboseLabel": "Term of lease", "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r870" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r769" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r743", "r754", "r764", "r789" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r742", "r753", "r763", "r788" ] }, "us-gaap_InvestmentOwnedAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentOwnedAtFairValue", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "label": "Investment Owned, Fair Value", "periodStartLabel": "Investment Owned, at Fair Value, Beginning Balance", "periodEndLabel": "Investment Owned, at Fair Value, Ending Balance", "documentation": "Fair value of investment in security owned." } } }, "auth_ref": [ "r569", "r578", "r579", "r580", "r582", "r583", "r584", "r585", "r586", "r589", "r590", "r600", "r601", "r640", "r642", "r643", "r645", "r651", "r652", "r654", "r655", "r656", "r659", "r660", "r662", "r664", "r665", "r720", "r729", "r889" ] }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseTermOfContract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease extension expiration term", "label": "Lessee, Operating Lease, Term of Contract", "verboseLabel": "Initial lease term", "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r868" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r742", "r753", "r763", "r788" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "auth_ref": [ "r744", "r755", "r765", "r790" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Senior unsecured notes, interest rate", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r24", "r347" ] }, "us-gaap_LessorOperatingLeaseRenewalTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeaseRenewalTerm", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Term of lease extension, years", "terseLabel": "Lease renewal term", "label": "Lessor, Operating Lease, Renewal Term", "documentation": "Term of lessor's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r870" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PartnerTypeOfPartnersCapitalAccountAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PartnerTypeOfPartnersCapitalAccountAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Partner Type", "label": "Partner Type [Axis]", "documentation": "Information by type or class of partner's capital account. Examples of classes of partners include, but not limited to, general partners, limited partners, preferred partners, and other ownership interests." } } }, "auth_ref": [ "r60", "r576" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r26", "r223", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r468", "r698", "r699", "r700", "r701", "r702", "r835" ] }, "us-gaap_DebtInstrumentMaturityDateDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentMaturityDateDescription", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Maturity Date, Description", "terseLabel": "Debt instrument amendment extended maturity date description", "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities." } } }, "auth_ref": [ "r25" ] }, "us-gaap_DebtInstrumentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentMaturityDate", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument maturity date", "label": "Debt Instrument, Maturity Date", "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r168", "r698", "r865" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax", "terseLabel": "Reclassification of foreign currency translation loss from AOCI", "negatedLabel": "Reclassification of foreign currency translation loss from AOCI", "verboseLabel": "Reclassification of foreign currency translation loss to earnings", "negatedTerseLabel": "Reclassification of foreign currency translation loss to earnings", "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation." } } }, "auth_ref": [ "r6", "r7", "r109", "r198", "r457" ] }, "us-gaap_InterestPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaid", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities, Total", "terseLabel": "Interest paid", "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities", "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities." } } }, "auth_ref": [ "r834" ] }, "us-gaap_DeferredRentReceivablesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRentReceivablesNet", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Deferred Rent Receivables, Net", "terseLabel": "Cash rent", "documentation": "Amount of excess of rental income recognized over rental payment required by lease." } } }, "auth_ref": [ "r158", "r159", "r160", "r869" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "mpw_NonCashImpairmentCharge": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "NonCashImpairmentCharge", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails" ], "lang": { "en-us": { "role": { "documentation": "Non-cash impairment charge.", "label": "Non-cash Impairment Charge", "terseLabel": "Non-cash impairment charge" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]", "documentation": "Name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r306", "r307", "r308" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesCreditLossReservesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherTenantUpdatesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Customer", "label": "Customer [Domain]", "documentation": "Single external customer or group of external customers." } } }, "auth_ref": [ "r274", "r705", "r863", "r886", "r887" ] }, "mpw_FinancingReceivableAllowancesOfCreditLossesRelatedToFinancialInstrumentsSold": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "FinancingReceivableAllowancesOfCreditLossesRelatedToFinancialInstrumentsSold", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfActivityInCreditLossReservesDetails" ], "lang": { "en-us": { "role": { "documentation": "Financing Receivable Allowances Of Credit Losses Related To Financial Instruments Sold", "label": "Financing Receivable Allowances Of Credit Losses Related To Financial Instruments Sold", "terseLabel": "Expected credit loss reserve related to financial instruments sold, repaid, or satisfied" } } }, "auth_ref": [] }, "mpw_ThreePointSixNineTwoPercentageSeniorUnsecuredNotesDueTwoThousandTwentyEightMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "ThreePointSixNineTwoPercentageSeniorUnsecuredNotesDueTwoThousandTwentyEightMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "3.692% Senior Unsecured Notes due 2028 [Member]", "label": "Three Point Six Nine Two Percentage Senior Unsecured Notes Due Two Thousand Twenty Eight [Member]", "documentation": "Three point six nine two percentage senior unsecured notes due two thousand twenty eight." } } }, "auth_ref": [] }, "mpw_PipelineHealthSystemMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PipelineHealthSystemMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Pipeline Health System [Member]", "label": "Pipeline Health System [Member]", "documentation": "Pipeline health system." } } }, "auth_ref": [] }, "mpw_EstimatedFeesToSellTheHospitals": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "EstimatedFeesToSellTheHospitals", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Estimated fees to Sell the hospitals.", "label": "Estimated Fees To Sell The Hospitals", "terseLabel": "Estimated fees to sell the hospitals" } } }, "auth_ref": [] }, "mpw_LoanTerm": { "xbrltype": "durationItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "LoanTerm", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Loan term", "label": "Loan Term", "documentation": "Loan term." } } }, "auth_ref": [] }, "mpw_ScheduleOfDevelopmentProjectsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "ScheduleOfDevelopmentProjectsTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Status on Current Development Projects", "label": "Schedule Of Development Projects Table [Text Block]", "documentation": "Schedule of development projects." } } }, "auth_ref": [] }, "mpw_StraightLineRentAndOtherRecoveryWriteOff": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "StraightLineRentAndOtherRecoveryWriteOff", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Straight-line rent and other (recovery) write-off", "label": "Straight Line Rent And Other Recovery Write Off", "documentation": "Straight line rent and other (recovery) write off.", "terseLabel": "Straight-line rent and other write-off" } } }, "auth_ref": [] }, "mpw_NetInvestmentInRealEstateAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "NetInvestmentInRealEstateAssets", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Net investment in real estate assets", "label": "Net Investment In Real Estate Assets", "documentation": "Net Investment In Real Estate Assets" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Axis]", "documentation": "Information by tax jurisdiction." } } }, "auth_ref": [ "r16" ] }, "srt_ScenarioForecastMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioForecastMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forecast", "label": "Forecast [Member]", "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact." } } }, "auth_ref": [ "r375", "r820", "r842" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax", "terseLabel": "Reclassification of interest rate swap gain from AOCI, net of tax", "negatedLabel": "Reclassification of interest rate swap gain from AOCI, net of tax", "negatedTerseLabel": "Reclassification of interest rate swap gain from AOCI, net of tax", "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r194", "r197" ] }, "mpw_AsprisChildrensServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "AsprisChildrensServicesMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aspris Children's Services [Member]", "label": "Aspris Children's Services [Member]", "documentation": "Aspris children's services." } } }, "auth_ref": [] }, "mpw_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesAndOtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesAndOtherLiabilities", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income tax liabilities and other liabilities, incurred", "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Deferred Tax Liabilities and Other Liabilities", "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed deferred tax liabilities and other liabilities." } } }, "auth_ref": [] }, "us-gaap_BuildingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BuildingMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Building [Member]", "label": "Building [Member]", "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities." } } }, "auth_ref": [ "r127" ] }, "mpw_PercentageOfDeferedRentReceivable": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PercentageOfDeferedRentReceivable", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Percentage of defered rent receivable.", "label": "Percentage of Defered Rent Receivable", "terseLabel": "Percentage of defered rent" } } }, "auth_ref": [] }, "mpw_NonCashRevenueFromDebtAndEquitySecuritiesReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "NonCashRevenueFromDebtAndEquitySecuritiesReceived", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "documentation": "Non-cash revenue from debt and equity securities received.", "label": "Non Cash Revenue From Debt And Equity Securities Received", "negatedLabel": "Non-cash revenue from debt and equity securities received" } } }, "auth_ref": [] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 1.0 }, "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails": { "parentTag": "mpw_GainLossOnDispositionOfRealEstate", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Real estate depreciation and amortization", "totalLabel": "Depreciation, Depletion and Amortization, Nonproduction, Total", "terseLabel": "Real estate depreciation and amortization", "label": "Depreciation, Depletion and Amortization, Nonproduction", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r10", "r53" ] }, "us-gaap_InterestAndOtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestAndOtherIncome", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Interest and Other Income, Total", "terseLabel": "Interest and other income", "label": "Interest and Other Income", "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [] }, "us-gaap_GainLossOnDispositionOfRealEstateDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnDispositionOfRealEstateDiscontinuedOperations", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (loss) on real estate dispositions", "label": "Gain (Loss) on Disposition of Real Estate, Discontinued Operations", "documentation": "Amount of difference between the carrying amount and the sales price of real estate properties sold as part of discontinued operations." } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpenseMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Other [Member]", "label": "Other Nonoperating Income (Expense) [Member]", "documentation": "Primary financial statement caption encompassing other nonoperating income (expense)." } } }, "auth_ref": [] }, "mpw_OtherInternationalAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "OtherInternationalAssetsMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "Other international assets.", "label": "Other International Assets [Member]", "terseLabel": "Other International Assets [Member]" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario", "label": "Scenario [Axis]", "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "auth_ref": [ "r237", "r375", "r806", "r807", "r842" ] }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Debt refinancing, deferred financing costs, and other financing activities", "documentation": "Amount of cash inflow (outflow) from financing activities classified as other." } } }, "auth_ref": [ "r809", "r831" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "periodEndLabel": "Additional Paid in Capital, Common Stock, Ending Balance", "periodStartLabel": "Additional Paid in Capital, Common Stock, Beginning Balance", "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r104" ] }, "mpw_NetBookValueOfLeasedProperty": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "NetBookValueOfLeasedProperty", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Net book value of leased property.", "label": "Net Book Value Of Leased Property", "terseLabel": "Net book value of leased property" } } }, "auth_ref": [] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 0.0 }, "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 0.0 }, "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 0.0 }, "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail": { "parentTag": "mpw_NetIncomeLessParticipatingSecuritiesShareInEarnings", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net income", "terseLabel": "Net income", "verboseLabel": "Net (loss) income", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r187", "r199", "r201", "r213", "r218", "r227", "r235", "r236", "r256", "r264", "r268", "r270", "r309", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r428", "r431", "r432", "r445", "r453", "r536", "r550", "r574", "r617", "r634", "r635", "r695", "r713", "r714", "r728", "r827", "r857" ] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario", "label": "Scenario [Domain]", "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "auth_ref": [ "r237", "r375", "r806", "r842" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnit" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share/Unit", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r238", "r250", "r251", "r252" ] }, "mpw_COVID19PandemicMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "COVID19PandemicMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "COVID-19 Pandemic [Member]", "label": "C O V I D19 Pandemic [Member]", "documentation": "COVID - 19 pandemic." } } }, "auth_ref": [] }, "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "label": "Variable Interest Entity, Not Primary Beneficiary [Member]", "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity." } } }, "auth_ref": [] }, "mpw_DiscountForLackOfMarketabilityPercentage": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "DiscountForLackOfMarketabilityPercentage", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Discount for lack of marketability percentage on Springstone equity investment", "label": "Discount for Lack of Marketability Percentage", "documentation": "Discount for Lack of Marketability Percentage" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureIncomeTaxes1" ], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r219", "r414", "r416", "r417", "r418", "r421", "r423", "r424", "r425", "r572" ] }, "mpw_FourPointSixTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyNineMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "FourPointSixTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyNineMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Four Point Six Two Five Percentage Senior Unsecured Notes Due Two Thousand Twenty Nine [Member]", "documentation": "Four point six two five percentage senior unsecured notes due two thousand twenty nine.", "terseLabel": "4.625% Senior Unsecured Notes due 2029 [Member]" } } }, "auth_ref": [] }, "mpw_NumberOfAncillaryPropertiesSold": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "NumberOfAncillaryPropertiesSold", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of ancillary properties sold.", "label": "Number Of Ancillary Properties Sold", "terseLabel": "Number of ancillary properties sold" } } }, "auth_ref": [] }, "mpw_RentBilled": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "RentBilled", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Rent billed", "label": "Rent Billed", "documentation": "Rent billed" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfVariableInterestEntitiesTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Variable Interest Entities [Table Text Block]", "terseLabel": "Summary of Carrying Value and Classification of the Assets and Maximum Exposure", "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide." } } }, "auth_ref": [ "r71", "r72", "r76", "r78", "r80" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails": { "parentTag": "mpw_GainLossOnDispositionOfRealEstate", "weight": 1.0, "order": 5.0 }, "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other (including fair value adjustments on securities)", "totalLabel": "Other Nonoperating Income (Expense), Total", "label": "Other Nonoperating Income (Expense)", "verboseLabel": "Other (expense) income", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r118" ] }, "mpw_RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVenturesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVenturesMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Investments in Unconsolidated Real Estate Joint Ventures [Member]", "label": "Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures [Member]", "documentation": "Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures [Member]" } } }, "auth_ref": [] }, "mpw_ReconstitutionOfAssetRelatedToProspect": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "ReconstitutionOfAssetRelatedToProspect", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Reconstitution of asset related to prospect.", "label": "Reconstitution Of Asset Related To Prospect", "terseLabel": "Reconstitution of asset" } } }, "auth_ref": [] }, "mpw_VariableInterestEquityInvestmentsCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "VariableInterestEquityInvestmentsCarryingAmount", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "documentation": "Variable interest equity investments carrying amount.", "label": "Variable Interest Equity Investments Carrying Amount.", "terseLabel": "Equity Investments Carrying Amount" } } }, "auth_ref": [] }, "mpw_InvestmentsInUnconsolidatedOperatingEntities": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "InvestmentsInUnconsolidatedOperatingEntities", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Investments in unconsolidated operating entities", "label": "Investments In Unconsolidated Operating Entities", "documentation": "Investments In Unconsolidated Operating Entities" } } }, "auth_ref": [] }, "us-gaap_VariableInterestEntityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityLineItems", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "label": "Variable Interest Entity [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r429", "r430", "r433", "r434", "r495", "r496", "r497" ] }, "mpw_RealEstateAccumulatedDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "RealEstateAccumulatedDepreciationAndAmortization", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "mpw_NetInvestmentInRealEstateAssets", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "negatedLabel": "Accumulated depreciation and amortization", "label": "Real Estate Accumulated Depreciation And Amortization", "documentation": "Real estate accumulated depreciation and amortization." } } }, "auth_ref": [] }, "mpw_AustraliaTransactionMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "AustraliaTransactionMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails" ], "lang": { "en-us": { "role": { "documentation": "Australia Transaction Member.", "label": "Australia Transaction [Member]", "terseLabel": "Australia Transaction [Member]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r373", "r476", "r477", "r591", "r592", "r593", "r594", "r595", "r614", "r616", "r639" ] }, "us-gaap_ScheduleOfVariableInterestEntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfVariableInterestEntitiesTable", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Variable Interest Entities [Table]", "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide." } } }, "auth_ref": [ "r71", "r72", "r76", "r78", "r80", "r429", "r430", "r433", "r434", "r495", "r496", "r497" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 1.0 }, "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail": { "parentTag": "mpw_NetIncomeLessParticipatingSecuritiesShareInEarnings", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Net income attributable to non-controlling interests", "negatedTerseLabel": "Non-controlling interests' share in net (income) loss", "totalLabel": "Net Income (Loss) Attributable to Noncontrolling Interest, Total", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r82", "r137", "r199", "r201", "r235", "r236", "r551", "r827" ] }, "us-gaap_DividendsCommonStockCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsCommonStockCash", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends (Distributions) declared", "label": "Dividends, Common Stock, Cash", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash." } } }, "auth_ref": [ "r132" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "mpw_FivePointTwoFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "FivePointTwoFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Five Point Two Five Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Six [Member]", "documentation": "Five point two five zero percentage senior unsecured notes due two thousand twenty six.", "terseLabel": "5.250% Senior Unsecured Notes due 2026 [Member]" } } }, "auth_ref": [] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "auth_ref": [ "r772" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r772" ] }, "mpw_SwissMedicalNetworkMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "SwissMedicalNetworkMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Swiss Medical Network [Member]", "label": "Swiss Medical Network [Member]", "documentation": "Swiss medical network." } } }, "auth_ref": [] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "auth_ref": [ "r772" ] }, "mpw_FacilitiesAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "FacilitiesAcquired", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Facilities acquired.", "label": "Facilities Acquired", "terseLabel": "Facilities acquired by the Prime" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasicLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicLineItems", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]", "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r241", "r245", "r247" ] }, "mpw_MacquarieAssetManagementMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "MacquarieAssetManagementMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Macquarie Asset Management [Member]", "label": "Macquarie Asset Management [Member]", "documentation": "Macquarie Asset Management." } } }, "auth_ref": [] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "auth_ref": [ "r773" ] }, "mpw_GeneralAcuteCareFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "GeneralAcuteCareFacilityMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "General acute care facility.", "label": "General Acute Care Facility [Member]", "terseLabel": "General Acute Care Facility [Member]" } } }, "auth_ref": [] }, "mpw_IncomeTaxBenefitRelatedToTheInitialLoanImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "IncomeTaxBenefitRelatedToTheInitialLoanImpairment", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Income tax benefit related to the initial loan impairment.", "label": "Income Tax Benefit Related To The Initial Loan Impairment", "terseLabel": "Income tax benefit related to the initial loan impairment" } } }, "auth_ref": [] }, "mpw_TwoPointFiveFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "TwoPointFiveFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyThreeMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2.550% Senior Unsecured Notes due 2023 [Member]", "label": "Two Point Five Five Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Three [Member]", "documentation": "Two point five five zero percentage senior unsecured notes due two thousand twenty three." } } }, "auth_ref": [] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r773" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Increase (decrease) in cash, cash equivalents, and restricted cash for period", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r3", "r121" ] }, "mpw_NumberOfPropertiesVacant": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "NumberOfPropertiesVacant", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of properties vacant.", "label": "Number of Properties Vacant", "terseLabel": "Number of properties vacant" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Earnings per common share (units) basic" } } }, "auth_ref": [] }, "mpw_GeneralAcuteCareHospitalsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "GeneralAcuteCareHospitalsMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "General Acute Care Facilities [Member]", "terseLabel": "General Acute Care Hospitals [Member]", "label": "General Acute Care Hospitals [Member]", "documentation": "General acute care hospitals." } } }, "auth_ref": [] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "auth_ref": [ "r773" ] }, "mpw_SummaryOfOperatingResultsFromPropertiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "SummaryOfOperatingResultsFromPropertiesTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Operating Results from Properties", "label": "Summary Of Operating Results From Properties [Table Text Block]", "documentation": "Summary of Operating results from properties." } } }, "auth_ref": [] }, "mpw_NumberOfFacilitiesHeldForSale": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "NumberOfFacilitiesHeldForSale", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherTenantUpdatesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of facilites agreed to sell", "label": "Number Of Facilities Held For Sale", "documentation": "Number of Facilities Held For Sale." } } }, "auth_ref": [] }, "us-gaap_LessorLeaseDescriptionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorLeaseDescriptionLineItems", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Lessor Lease Description [Line Items]", "label": "Lessor, Lease, Description [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r470" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "auth_ref": [ "r773" ] }, "mpw_StockIssuedDuringPeriodSharesStockVestingAndAmortizationOfStockBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "StockIssuedDuringPeriodSharesStockVestingAndAmortizationOfStockBasedCompensation", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "terseLabel": "Stock (Unit) vesting and amortization of stock (unit)-based compensation (shares)", "label": "Stock Issued During Period Shares Stock Vesting And Amortization Of Stock Based Compensation", "documentation": "Stock issued during period, shares, stock vesting and amortization of stock-based compensation." } } }, "auth_ref": [] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableRecoveries", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesCreditLossReservesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit loss recovery", "label": "Accounts Receivable, Allowance for Credit Loss, Recovery", "documentation": "Amount of increase in allowance for credit loss on accounts receivable, from recovery." } } }, "auth_ref": [ "r317" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r773" ] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Repayments of Long-term Debt, Total", "negatedLabel": "Payments of term debt", "label": "Repayments of Long-Term Debt", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r38", "r570" ] }, "mpw_StraightLineRentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "StraightLineRentReceivables", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherTenantUpdatesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Straight-line rent receivables.", "label": "Straight-Line Rent Receivables", "terseLabel": "Straight-line rent receivables" } } }, "auth_ref": [] }, "mpw_CaremaxIncorporatedMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "CaremaxIncorporatedMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "CareMax Incorporated.", "label": "CareMax Incorporated [Member]", "terseLabel": "Caremax [Member]" } } }, "auth_ref": [] }, "mpw_FinancialInstrumentsMeasuredAtFairValueOnRecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "FinancialInstrumentsMeasuredAtFairValueOnRecurringBasisLineItems", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDlomBySensitivityAnalysisByUsingBasisPointVariationsDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]", "label": "Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]", "documentation": "Financial instruments measured at fair value on recurring basis." } } }, "auth_ref": [] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r773" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rate changes", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r456" ] }, "mpw_NumberOfFacilities": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "NumberOfFacilities", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Number of facilities", "label": "Number Of Facilities", "documentation": "Number of facilities." } } }, "auth_ref": [] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r773" ] }, "mpw_RealEstateAndOtherImpairmentChargesRecovery": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "RealEstateAndOtherImpairmentChargesRecovery", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Real estate and other impairment charges (recovery)", "label": "Real Estate And Other Impairment Charges (Recovery)", "documentation": "Real estate and other impairment charges (recovery)." } } }, "auth_ref": [] }, "mpw_OperatorConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "OperatorConcentrationRiskMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operator Concentration Risk [Member]", "label": "Operator Concentration Risk [Member]", "documentation": "Operator concentration risk." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Securities Act File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "mpw_CapitalRestructuringCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "CapitalRestructuringCosts", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Capital restructuring costs.", "label": "Capital Restructuring Costs", "terseLabel": "Capital restructuring costs" } } }, "auth_ref": [] }, "mpw_RedevelopmentOfRecoveryReceivablesPriorStormAndFloodDamage": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "RedevelopmentOfRecoveryReceivablesPriorStormAndFloodDamage", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Redevelopment of recovery receivables prior storm and flood damage.", "label": "Redevelopment Of Recovery Receivables Prior Storm and Flood Damage", "terseLabel": "Redevelopment recovery receivables of prior storm and flood damage" } } }, "auth_ref": [] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r774" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency", "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r447", "r448", "r449", "r450", "r451" ] }, "us-gaap_EarningsPerShareDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDilutedAbstract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Earnings per common share (units) diluted" } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total", "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period", "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r39", "r121", "r216" ] }, "mpw_LoansAndOrEquityInvestmentsInVariableInterestEntities": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "LoansAndOrEquityInvestmentsInVariableInterestEntities", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Loans and/or equity investments in variable interest entities", "label": "Loans And Or Equity Investments In Variable Interest Entities", "documentation": "Loans and/or equity investments in variable interest entities." } } }, "auth_ref": [] }, "mpw_CertainObligationsAndReceivableSatisfiedAndRealEstateSold": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "CertainObligationsAndReceivableSatisfiedAndRealEstateSold", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "documentation": "Certain obligations and receivables satisfied and real estate sold.", "label": "Certain obligations and receivable satisfied and real estate sold", "terseLabel": "Certain obligations and receivables satisfied and real estate sold" } } }, "auth_ref": [] }, "us-gaap_ReceivablesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivablesFairValueDisclosure", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Receivables, Fair Value Disclosure, Total", "terseLabel": "Interest and rent receivables, Fair value", "label": "Receivables, Fair Value Disclosure", "documentation": "Fair value portion of receivables, including, but not limited to, trade account receivables, note receivables, and loan receivables." } } }, "auth_ref": [ "r147", "r866" ] }, "mpw_VibraHealthcareLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "VibraHealthcareLLCMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherTenantUpdatesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vibra Healthcare LLC [Member]", "documentation": "Vibra Healthcare, LLC.", "label": "Vibra Healthcare L L C [Member]" } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r776" ] }, "mpw_NumberOfRemainingFacilitiesSold": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "NumberOfRemainingFacilitiesSold", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of remaining facilities sold.", "label": "Number of Remaining Facilities Sold", "terseLabel": "Number of remaining facilities sold" } } }, "auth_ref": [] }, "mpw_FavorableFairMarketValueAdjustmentOnInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "FavorableFairMarketValueAdjustmentOnInvestment", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Favorable fair market value adjustment on investment", "label": "Favorable Fair Market Value Adjustment On Investment", "documentation": "Favorable fair market value adjustment on investment." } } }, "auth_ref": [] }, "us-gaap_LessorLeaseDescriptionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorLeaseDescriptionTable", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Lessor Lease Description [Table]", "label": "Lessor, Lease, Description [Table]", "documentation": "Disclosure of information about lessor's leases." } } }, "auth_ref": [ "r470" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r775" ] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "auth_ref": [ "r779" ] }, "mpw_GlobalAssetManagerMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "GlobalAssetManagerMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Global Asset Manager [Member]", "documentation": "Global Asset Manager." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r777" ] }, "mpw_InpatientRehabilitationHospitalMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "InpatientRehabilitationHospitalMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inpatient Rehabilitation Hospitals [Member]", "label": "Inpatient Rehabilitation Hospital [Member]", "documentation": "Inpatient Rehabilitation Hospital." } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r778" ] }, "mpw_FinancialInstrumentsMeasuredAtFairValueOnRecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "FinancialInstrumentsMeasuredAtFairValueOnRecurringBasisTable", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDlomBySensitivityAnalysisByUsingBasisPointVariationsDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instruments Measured At Fair Value On Recurring Basis [Table]", "label": "Financial Instruments Measured At Fair Value On Recurring Basis [Table]", "documentation": "Financial Instruments Measured At Fair Value On Recurring Basis [Table]" } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r778" ] }, "mpw_SummaryOfCreditLossReservesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "SummaryOfCreditLossReservesTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Activity in Credit Loss reserves", "label": "Summary Of Credit Loss Reserves [Table Text Block]", "documentation": "Summary of credit loss reserves." } } }, "auth_ref": [] }, "mpw_PoliclinicoDiMonzaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PoliclinicoDiMonzaMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Policlinico di Monza [Member]", "label": "Policlinico di Monza [Member]", "documentation": "Policlinico di Monza." } } }, "auth_ref": [] }, "mpw_CommonSpiritMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "CommonSpiritMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "Common spirit.", "label": "Common Spirit [Member]", "terseLabel": "Common Spirit [Member]" } } }, "auth_ref": [] }, "mpw_ShareholderLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "ShareholderLoanMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Shareholder Loan [Member]", "documentation": "Shareholder Loan." } } }, "auth_ref": [] }, "mpw_MptOperatingPartnershipLPMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "MptOperatingPartnershipLPMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "MPT Operating Partnership, L.P. [Member]", "label": "Mpt Operating Partnership L P [Member]", "documentation": "MPT Operating Partnership L.P" } } }, "auth_ref": [] }, "mpw_LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "mpw_GrossInvestmentInRealEstateAssets", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Land, buildings and improvements, intangible lease assets, and other", "label": "Land Buildings And Improvements Intangible Lease Assets And Other", "documentation": "Land buildings and improvements intangible lease assets and other." } } }, "auth_ref": [] }, "mpw_NumberOfFacilitiesSold": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "NumberOfFacilitiesSold", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Number of facilities sold", "label": "Number Of Facilities Sold", "documentation": "Number of facilities sold." } } }, "auth_ref": [] }, "mpw_ProceedsReceivedToPaydownOutstandingLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "ProceedsReceivedToPaydownOutstandingLoan", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Proceeds received to paydown outstanding loan.", "label": "Proceeds Received To Paydown Outstanding Loan", "terseLabel": "Proceeds received to paydown outstanding loan" } } }, "auth_ref": [] }, "mpw_PercentageOfDiscountOnInvestment": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PercentageOfDiscountOnInvestment", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of discount on investment", "label": "Percentage of Discount on Investment", "documentation": "Percentage of discount on investment." } } }, "auth_ref": [] }, "mpw_StockIssuedDuringPeriodValueStockVestingSatisfactionOfTaxWithholding": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "StockIssuedDuringPeriodValueStockVestingSatisfactionOfTaxWithholding", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "negatedLabel": "Stock vesting - satisfaction of tax withholding", "terseLabel": "Stock vesting - satisfaction of tax withholding", "label": "Stock Issued During Period Value Stock Vesting Satisfaction Of Tax Withholding", "documentation": "Stock issued during period value stock vesting satisfaction of tax withholding." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Interest in Related Party and Related Loans Measured at Fair Value on Recurring Basis", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r447", "r448" ] }, "mpw_PaymentsForCapitalAdditionsAndOtherInvestmentsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PaymentsForCapitalAdditionsAndOtherInvestmentsNet", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Capital additions and other investments, net", "label": "Payments For Capital Additions And Other Investments Net", "documentation": "Payments for capital additions and other investments net." } } }, "auth_ref": [] }, "mpw_CumulativeBenefitCatchupFromAdjustingPayoutProbability": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "CumulativeBenefitCatchupFromAdjustingPayoutProbability", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Cumulative benefit catchup from adjusting payout probability.", "label": "Cumulative Benefit Catchup From Adjusting Payout Probability", "terseLabel": "Cumulative benefit catchup from adjusting payout probability" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "terseLabel": "Common stock remaining for future stock awards transferred to the equity incentive plan", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r61" ] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails" ], "lang": { "en-us": { "role": { "label": "Percentage of equity investment", "verboseLabel": "Passive equity interest", "terseLabel": "Ownership interest", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r306" ] }, "us-gaap_DeferredFinanceCostsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsGross", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Debt Issuance Costs, Gross", "terseLabel": "Accelerated amortization debt issue costs", "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r94" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "terseLabel": "Reserved shares of new common stock for awards under the Equity Incentive Plan", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r711" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "mpw_IncomeTaxesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "IncomeTaxesLineItems", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes [Line Items]", "label": "Income Taxes [Line Items]", "documentation": "Income Taxes [Line Items]" } } }, "auth_ref": [] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Interest Expense, Total", "terseLabel": "Interest", "label": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r94", "r152", "r206", "r259", "r466", "r621", "r727", "r890" ] }, "mpw_RepaymentsOfRemainingShortTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "RepaymentsOfRemainingShortTermDebt", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Repayment received on credit facility availed, total amount", "label": "Repayments Of Remaining Short Term Debt", "documentation": "Repayments of remaining short term debt." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year", "terseLabel": "2023", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year." } } }, "auth_ref": [ "r838" ] }, "mpw_OtherDomesticAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "OtherDomesticAssetsMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "Other domestic assets.", "label": "Other Domestic Assets [Member]", "terseLabel": "Other Domestic Assets [Member]" } } }, "auth_ref": [] }, "mpw_PercentageOfPropertiesOccupiedByTenants": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PercentageOfPropertiesOccupiedByTenants", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of properties occupied by tenants", "label": "Percentage of Properties Occupied By Tenants", "documentation": "Percentage of properties occupied by tenants." } } }, "auth_ref": [] }, "mpw_DebtRefinancingCharge": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "DebtRefinancingCharge", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Debt refinancing costs", "label": "Debt Refinancing Charge", "documentation": "Debt refinancing charge." } } }, "auth_ref": [] }, "mpw_ReclassificationOfInterestRateSwapGainToEarningsNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "ReclassificationOfInterestRateSwapGainToEarningsNetOfTax", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "documentation": "Reclassification of interest rate swap gain to earnings, net of tax.", "label": "Reclassification Of Interest Rate Swap Gain To Earnings, Net Of Tax", "terseLabel": "Reclassification of interest rate swap gain to earnings, net of tax" } } }, "auth_ref": [] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesRevenueNetMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue [Member]", "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r274", "r811" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r730" ] }, "mpw_AcuteCareCampusMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "AcuteCareCampusMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Acute Care Campus [Member]", "label": "Acute Care Campus [Member]", "documentation": "Acute care campus." } } }, "auth_ref": [] }, "mpw_LeasesAnnualRentEscalationsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "LeasesAnnualRentEscalationsPercentage", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Annual rent escalations", "label": "Leases Annual Rent Escalations Percentage", "documentation": "Leases annual rent escalations percentage." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "All Award Types", "terseLabel": "All Award Types", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406" ] }, "mpw_StraightLineRentReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "StraightLineRentReceivable", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Straight-line rent receivables", "label": "Straight Line Rent Receivable", "documentation": "Straight-line rent receivable" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r377", "r378", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r377", "r378", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406" ] }, "mpw_UnpaidRentAndInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "UnpaidRentAndInterest", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Unpaid rent and interest.", "label": "Unpaid Rent and Interest", "terseLabel": "Unpaid rent and interest" } } }, "auth_ref": [] }, "mpw_MaximumIncrementalCreditFacility": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "MaximumIncrementalCreditFacility", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Maximum incremental credit facility", "label": "Maximum Incremental Credit Facility", "terseLabel": "Maximum incremental credit facility" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Maturity, Year One", "terseLabel": "2024", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r12", "r223", "r357" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location", "label": "Balance Sheet Location [Axis]", "documentation": "Information by location on balance sheet (statement of financial position)." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Maturity, Year Four", "terseLabel": "2027", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r12", "r223", "r357" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r732" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Maturity, Year Three", "terseLabel": "2026", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r12", "r223", "r357" ] }, "us-gaap_VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Variable Interest Entity, Nonconsolidated, Comparison of Carrying Amount of Assets and Liabilities to Maximum Loss Exposure, Total", "label": "Variable Interest Entity, Nonconsolidated, Comparison of Carrying Amount of Assets and Liabilities to Maximum Loss Exposure", "terseLabel": "Carrying Amount", "documentation": "Difference between the carrying amount of assets and liabilities in the reporting entity's statement of financial position that relate to the reporting entity's variable interest in the variable interest entity (VIE) and the reporting entity's maximum exposure to loss as a result of its involvement with the VIE, where the reporting entity is not the VIE's primary beneficiary." } } }, "auth_ref": [ "r73" ] }, "stpr_UT": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "UT", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "UTAH", "terseLabel": "Utah [Member]" } } }, "auth_ref": [] }, "mpw_PayableDueToParentCompany": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PayableDueToParentCompany", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Payable due to Medical Properties Trust, Inc.", "label": "Payable Due To Parent Company", "documentation": "Payable due to parent company" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Maturity, Year Two", "terseLabel": "2025", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r12", "r223", "r357" ] }, "stpr_TX": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "TX", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "label": "TEXAS", "terseLabel": "Texas [Member]" } } }, "auth_ref": [] }, "mpw_StewardEquityInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "StewardEquityInterestMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Steward Equity Investment.", "label": "Steward Equity Investment [Member]", "terseLabel": "Steward Equity Investment [Member]" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "mpw_ProceedsFromTheSaleOfFirstTranchePrepay": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "ProceedsFromTheSaleOfFirstTranchePrepay", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Proceeds from the sale of first tranche prepay.", "label": "Proceeds from the Sale of First Tranche Prepay", "terseLabel": "Proceeds from the sale of first tranche prepay." } } }, "auth_ref": [] }, "mpw_RemainingOutstandingDeferredRentToBeReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "RemainingOutstandingDeferredRentToBeReceived", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesCoronavirusCovid19RentDeferralsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Percentage of deferred revenue lease", "terseLabel": "Remaining outstanding deferred rent to be received", "label": "Remaining Outstanding Deferred Rent To Be Received", "documentation": "Remaining outstanding deferred rent to be received." } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r26", "r54" ] }, "mpw_PhpHoldingsEquityInvestmentMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PhpHoldingsEquityInvestmentMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Php holdings equity investment.", "label": "PHP Holdings Equity Investment [Member]", "terseLabel": "PHP Holdings Equity Investment [Member]" } } }, "auth_ref": [] }, "mpw_BehavioralHealthHospitalsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "BehavioralHealthHospitalsMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Behavioral health hospitals.", "label": "Behavioral Health Hospitals [Member]", "terseLabel": "Behavioral Health Hospitals [Member]" } } }, "auth_ref": [] }, "mpw_EuroDenominatedBorrowingsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "EuroDenominatedBorrowingsMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "EURO-denominated Borrowings [Member]", "label": "EURO Denominated Borrowings [Member]", "documentation": "EURO denominated borrowings." } } }, "auth_ref": [] }, "mpw_BehavioralHealthFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "BehavioralHealthFacilitiesMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "Behavioral health facilities.", "label": "Behavioral Health Facilities [Member]" } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "us-gaap_PaymentsOfOrdinaryDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfOrdinaryDividends", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Payments of Ordinary Dividends, Total", "label": "Payments of Ordinary Dividends", "negatedLabel": "Dividends paid", "documentation": "Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings." } } }, "auth_ref": [ "r37" ] }, "mpw_OtherInvestmentOnSecuredLoanWithCreditFacilityCollateral": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "OtherInvestmentOnSecuredLoanWithCreditFacilityCollateral", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Other investment on secured loan with credit facility collateral", "label": "Other Investment On Secured Loan with Credit Facility Collateral", "documentation": "Other investment on secured loan with credit facility collateral." } } }, "auth_ref": [] }, "mpw_SummaryOfInvestmentsInUnconsolidatedOperatingEntitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "SummaryOfInvestmentsInUnconsolidatedOperatingEntitiesTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "label": "Summary Of Investments In Unconsolidated Operating Entities [Table Text Block]", "documentation": "Summary of investments in unconsolidated operating entities.", "terseLabel": "Summary of Investments in Unconsolidated Operating Entities" } } }, "auth_ref": [] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical", "label": "Geographical [Axis]", "documentation": "Information by geographical components." } } }, "auth_ref": [ "r172", "r182", "r272", "r273", "r580", "r583", "r585", "r642", "r648", "r654", "r664", "r671", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r686", "r704", "r720", "r863", "r886" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, $0.001 par value. Authorized 750,000 shares; issued and outstanding - 598,444 shares at September 30, 2023 and 597,476 shares at December 31, 2022", "periodEndLabel": "Common Stock, Value, Issued, Ending Balance", "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance", "totalLabel": "Common Stock, Value, Issued, Total", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r103", "r543", "r715" ] }, "mpw_GainLossOnDispositionOfRealEstate": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "GainLossOnDispositionOfRealEstate", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails" ], "lang": { "en-us": { "role": { "totalLabel": "(Loss) income from real estate dispositions, net", "label": "Gain Loss on Disposition of Real Estate", "documentation": "Gain loss on disposition of real estate." } } }, "auth_ref": [] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Entities", "label": "Consolidated Entities [Domain]", "documentation": "Entity or group of entities consolidated into reporting entity." } } }, "auth_ref": [ "r173", "r223", "r429", "r430", "r433", "r434", "r479", "r683", "r821", "r822", "r823", "r856", "r859", "r860" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax (expense) benefit", "terseLabel": "Income tax expense (benefit)", "totalLabel": "Income Tax Expense (Benefit), Total", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r162", "r167", "r235", "r236", "r262", "r415", "r422", "r558" ] }, "mpw_FreestandingERUrgentCareFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "FreestandingERUrgentCareFacilitiesMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "Freestanding E R urgent care facilities.", "label": "Freestanding E R Urgent Care Facilities [Member]", "terseLabel": "Freestanding ER/Urgent Care Facilities [Member]" } } }, "auth_ref": [] }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "negatedLabel": "Distributions to non-controlling interests", "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders." } } }, "auth_ref": [ "r132" ] }, "us-gaap_OtherNoncashIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncashIncomeExpense", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Other Noncash Income (Expense), Total", "negatedLabel": "Other adjustments", "label": "Other Noncash Income (Expense)", "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other." } } }, "auth_ref": [ "r123" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Entities", "label": "Consolidated Entities [Axis]", "documentation": "Information by consolidated entity or group of entities." } } }, "auth_ref": [ "r173", "r223", "r429", "r430", "r433", "r434", "r479", "r683", "r821", "r822", "r823", "r856", "r859", "r860" ] }, "mpw_NegativeHundredBasisPointsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "NegativeHundredBasisPointsMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDlomBySensitivityAnalysisByUsingBasisPointVariationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "- 100 Basis Points [Member]", "label": "Negative Hundred Basis Points [Member]", "documentation": "Negative Hundred Basis Points." } } }, "auth_ref": [] }, "mpw_StraightLineRentRevenueAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "StraightLineRentRevenueAndOther", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Straight-line rent revenue and other", "label": "Straight Line Rent Revenue And Other", "documentation": "Straight-line rent revenue and other." } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r768" ] }, "us-gaap_ProceedsFromSaleOfOtherInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfOtherInvestments", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Sale of investment", "label": "Proceeds from Sale of Other Investments", "documentation": "Amount of cash inflow from the sale of investments classified as other." } } }, "auth_ref": [ "r808" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Diluted weighted-average common shares", "terseLabel": "Weighted average shares (units) outstanding diluted", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r240", "r249" ] }, "mpw_TermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "TermLoanMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Term Loan [Member]", "label": "Term Loan [Member]", "documentation": "Term loan." } } }, "auth_ref": [] }, "mpw_ObligationsToTenantsAndOtherLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "ObligationsToTenantsAndOtherLeaseLiabilities", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Obligations to tenants and other lease liabilities", "label": "Obligations To Tenants And Other Lease Liabilities", "documentation": "Obligations to tenants and other lease liabilities." } } }, "auth_ref": [] }, "us-gaap_CorporateJointVentureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateJointVentureMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Joint Venture [Member]", "label": "Corporate Joint Venture [Member]", "verboseLabel": "Corporate Joint Venture [Member]", "documentation": "Corporation owned and operated by a small group of ventures to accomplish a mutually beneficial venture or project." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleOfRealEstate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfRealEstate", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Expected cash proceeds on transaction close", "totalLabel": "Proceeds from Sale of Real Estate, Total", "terseLabel": "Proceeds from sale of facilities", "label": "Proceeds from Sale of Real Estate", "documentation": "Cash received for the sale of real estate that is not part of an investing activity during the current period." } } }, "auth_ref": [ "r119" ] }, "mpw_RealEstatePartnershipMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "RealEstatePartnershipMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Real Estate Partnership [Member]", "label": "Real Estate Partnership [Member]", "documentation": "Real estate partnership." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total", "verboseLabel": "Basic weighted-average common shares", "terseLabel": "Weighted average shares (units) outstanding basic", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r239", "r249" ] }, "mpw_HmHospitalMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "HmHospitalMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails" ], "lang": { "en-us": { "role": { "terseLabel": "HM Hospital [Member]", "label": "HM Hospital [Member]", "documentation": "HM Hospital." } } }, "auth_ref": [] }, "us-gaap_LimitedPartnerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LimitedPartnerMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Limited Partner [Member]", "label": "Limited Partner [Member]", "documentation": "Party to a partnership business who has limited liability." } } }, "auth_ref": [] }, "mpw_ConstructionInProgressEquipmentAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "ConstructionInProgressEquipmentAndOther", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Construction in progress and other", "label": "Construction In Progress Equipment And Other", "documentation": "Construction in progress equipment and other." } } }, "auth_ref": [] }, "us-gaap_ResidualValueOfLeasedAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResidualValueOfLeasedAsset", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Residual Value of Leased Asset, Total", "terseLabel": "Carrying value of lease requiring residual value guarantee", "label": "Residual Value of Leased Asset", "documentation": "Amount of residual asset covered by residual value guarantee. Excludes guarantee considered to be lease payments for lessor." } } }, "auth_ref": [ "r474" ] }, "mpw_ExceptedProceedsInCash": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "ExceptedProceedsInCash", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Excepted proceeds in cash.", "label": "Excepted Proceeds in Cash", "terseLabel": "Excepted proceeds in cash" } } }, "auth_ref": [] }, "us-gaap_GeneralPartnerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralPartnerMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "General Partner [Member]", "label": "General Partner [Member]", "documentation": "Party to a partnership business who has unlimited liability." } } }, "auth_ref": [] }, "us-gaap_MortgagesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MortgagesMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Mortgage Loans [Member]", "label": "Mortgages [Member]", "documentation": "A loan to finance the purchase of real estate where the lender has a lien on the property as collateral for the loan." } } }, "auth_ref": [] }, "mpw_InterimCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "InterimCreditFacilityMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Interim Credit Facility [Member]", "label": "Interim Credit Facility [Member]", "documentation": "Interim credit facility." } } }, "auth_ref": [] }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDlomBySensitivityAnalysisByUsingBasisPointVariationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated Increase (Decrease) in Fair Value", "totalLabel": "Estimated Increase (Decrease) in Fair Value", "label": "Investments in and Advances to Affiliates, at Fair Value, Period Increase (Decrease)", "documentation": "Amount of increase (decrease) in the investments in and advances to affiliates." } } }, "auth_ref": [ "r897" ] }, "us-gaap_NumberOfStatesInWhichEntityOperates": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfStatesInWhichEntityOperates", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Number of states", "label": "Number of States in which Entity Operates", "documentation": "The number of states the entity operates in as of the balance sheet date." } } }, "auth_ref": [] }, "mpw_PaydownOnDebtInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PaydownOnDebtInstruments", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Paydown on debt instruments.", "label": "Paydown On Debt Instruments", "terseLabel": "Pay down of debt instruments" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Proceeds from Equity Method Investment, Distribution, Return of Capital", "terseLabel": "Proceeds from return of equity investments", "documentation": "Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities." } } }, "auth_ref": [ "r214", "r830" ] }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEquityMethodInvestmentsTable", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Equity Method Investments [Table]", "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available." } } }, "auth_ref": [ "r187", "r218", "r306", "r307", "r308", "r309", "r453" ] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesCreditLossReservesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherTenantUpdatesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Customer", "label": "Customer [Axis]", "documentation": "Information by name or description of a single external customer or a group of external customers." } } }, "auth_ref": [ "r274", "r705", "r863", "r886", "r887" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Total", "verboseLabel": "Acquisition loan", "terseLabel": "Total assets acquired", "label": "Additional mortgage loan", "documentation": "Amount of assets acquired at the acquisition date." } } }, "auth_ref": [ "r65" ] }, "mpw_PrimeHealthCareServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PrimeHealthCareServicesMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Prime [Member]", "documentation": "Prime Health Care Services.", "label": "Prime Health Care Services [Member]", "terseLabel": "Prime Healthcare Services [Member]" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfSecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfSecuredDebt", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Proceeds from expected secured debt", "terseLabel": "Proceeds from secured debt", "label": "Proceeds from Issuance of Secured Debt", "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt." } } }, "auth_ref": [ "r36" ] }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Equity Method Investments [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r218", "r306", "r307", "r308", "r309", "r453" ] }, "mpw_MedianKlinikenSARLMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "MedianKlinikenSARLMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails" ], "lang": { "en-us": { "role": { "label": "Median Kliniken S A R L [Member]", "documentation": "Median Kliniken S A R L [Member]", "terseLabel": "MEDIAN [Member]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "verboseLabel": "Common Units [Member]", "terseLabel": "Common Par Value [Member]", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r718", "r719", "r720", "r722", "r723", "r724", "r725", "r839", "r840", "r864", "r888", "r892" ] }, "mpw_PrioryGroupMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PrioryGroupMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Priory [Member]", "terseLabel": "Priory Group [Member]", "label": "Priory Group [Member]", "documentation": "Priory Group." } } }, "auth_ref": [] }, "us-gaap_DirectFinancingLeaseLeaseReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DirectFinancingLeaseLeaseReceivable", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "parentTag": "us-gaap_DirectFinancingLeaseNetInvestmentInLease", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum lease payments receivable", "label": "Direct Financing Lease, Lease Receivable", "documentation": "Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term, guaranteed by lessee or other third party unrelated to lessor, from direct financing lease." } } }, "auth_ref": [ "r473" ] }, "mpw_FavorableNonCashFairValueAdjustmentOnInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "FavorableNonCashFairValueAdjustmentOnInvestment", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Favorable non-cash fair value adjustment on investment", "label": "Favorable Non Cash Fair Value Adjustment On Investment", "documentation": "Favorable non-cash fair value adjustment on investment." } } }, "auth_ref": [] }, "mpw_NumberOfPropertiesLeased": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "NumberOfPropertiesLeased", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of properties leased.", "label": "Number Of Properties Leased", "terseLabel": "Number of properties leased" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Plan Modification, Incremental Cost", "terseLabel": "Incremental expense of stock awards", "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification." } } }, "auth_ref": [ "r409" ] }, "mpw_ZeroPointNineNineThreePercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "ZeroPointNineNineThreePercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "0.993% Senior Unsecured Notes due 2026 [Member]", "label": "Zero Point Nine Nine Three Percentage Senior Unsecured Notes Due Two Thousand Twenty Six [Member]", "documentation": "Zero point nine nine three percentage senior unsecured notes due two thousand twenty six." } } }, "auth_ref": [] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r769" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities, Total", "negatedLabel": "Liabilities assumed", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "documentation": "Amount of liabilities assumed at the acquisition date." } } }, "auth_ref": [ "r65" ] }, "mpw_InvestmentsInUnconsolidatedOperatingEntitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "InvestmentsInUnconsolidatedOperatingEntitiesMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Investments In Unconsolidated Operating Entities [Member]", "label": "Investments In Unconsolidated Operating Entities [Member]", "documentation": "Investments In Unconsolidated Operating Entities [Member]" } } }, "auth_ref": [] }, "mpw_PercentageOfDividendsPayableOnSeniorUnsecuredNotes": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "PercentageOfDividendsPayableOnSeniorUnsecuredNotes", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of dividends which could be paid from operation funds", "label": "Percentage Of Dividends Payable On Senior Unsecured Notes", "documentation": "Percentage of dividends payable on senior unsecured notes." } } }, "auth_ref": [] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r768" ] }, "mpw_WatsonvilleCommunityHospitalMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "WatsonvilleCommunityHospitalMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesCreditLossReservesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Watsonville Community Hospital [Member]", "label": "Watsonville Community Hospital [Member]", "documentation": "Watsonville community hospital." } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r329", "r330", "r620" ] }, "us-gaap_LineOfCreditFacilityInitiationDate1": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityInitiationDate1", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit , entered date", "label": "Line of Credit Facility, Initiation Date", "documentation": "Date the credit facility first became available, in YYYY-MM-DD format." } } }, "auth_ref": [ "r22" ] }, "us-gaap_LeasesAcquiredInPlaceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAcquiredInPlaceMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Leases, Acquired-in-Place [Member]", "terseLabel": "In-place lease intangibles [Member]", "documentation": "This element represents the amount of value allocated by a lessor (acquirer) to lease agreements which exist at acquisition of a leased property. Such amount may include the value assigned to tenant relationships and excludes the market adjustment component of the value assigned for above or below-market leases acquired." } } }, "auth_ref": [] }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtTables" ], "lang": { "en-us": { "role": { "terseLabel": "Principal Payments Due on Debt", "label": "Contractual Obligation, Fiscal Year Maturity [Table Text Block]", "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation." } } }, "auth_ref": [ "r837" ] }, "country_CO": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "CO", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Colombia [Member]", "label": "COLOMBIA" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r330", "r620" ] }, "us-gaap_ScheduleOfSensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Effects of Movement in DLOM by Sensitivity Analysis by Using Basis Point Variations", "label": "Schedule of Sensitivity Analysis of Fair Value, Transferor's Interests in Transferred Financial Assets [Table Text Block]", "documentation": "Tabular disclosure of a sensitivity analysis or stress test showing the hypothetical effect on the fair value of the transferor's interests in transferred financial assets (including any servicing assets or servicing liabilities) of two or more unfavorable variations from the expected levels for each key assumption that is reported, independently determined from any change in another key assumption, and a description of the objectives, methodology, and limitations of the sensitivity analysis or stress test." } } }, "auth_ref": [ "r880" ] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 0.0 }, "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "negatedLabel": "Debt, net Book value", "totalLabel": "Debt, net", "terseLabel": "Debt, net", "label": "Long-Term Debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r21", "r144", "r353", "r364", "r699", "r700", "r885" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Member]", "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r465", "r480" ] }, "us-gaap_LineOfCreditFacilityExpirationDate1": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityExpirationDate1", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Expiration Date", "terseLabel": "Line of credit, terminated date", "documentation": "Date the credit facility terminates, in YYYY-MM-DD format." } } }, "auth_ref": [ "r22" ] }, "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net, Total", "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net", "terseLabel": "Deferred gains from our interest rate swap in AOCI", "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments." } } }, "auth_ref": [ "r20", "r86" ] }, "country_DE": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "DE", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "GERMANY", "terseLabel": "Germany [Member]" } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement", "label": "Statistical Measurement [Axis]", "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r333", "r334", "r335", "r336", "r372", "r374", "r403", "r404", "r405", "r487", "r514", "r559", "r587", "r588", "r641", "r647", "r649", "r650", "r661", "r684", "r685", "r696", "r703", "r709", "r717", "r720", "r854", "r861", "r875", "r876", "r877", "r878", "r879" ] }, "country_AU": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "AU", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Australia [Member]", "label": "AUSTRALIA" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum [Member]", "label": "Maximum [Member]", "documentation": "Upper limit of the provided range." } } }, "auth_ref": [ "r333", "r334", "r335", "r336", "r374", "r514", "r559", "r587", "r588", "r641", "r647", "r649", "r650", "r661", "r684", "r685", "r696", "r703", "r709", "r717", "r861", "r874", "r875", "r876", "r877", "r878", "r879" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement", "label": "Statistical Measurement [Domain]", "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r333", "r334", "r335", "r336", "r372", "r374", "r403", "r404", "r405", "r487", "r514", "r559", "r587", "r588", "r641", "r647", "r649", "r650", "r661", "r684", "r685", "r696", "r703", "r709", "r717", "r720", "r854", "r861", "r875", "r876", "r877", "r878", "r879" ] }, "country_ES": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "ES", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "label": "SPAIN", "terseLabel": "Spain [Member]" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum [Member]", "label": "Minimum [Member]", "documentation": "Lower limit of the provided range." } } }, "auth_ref": [ "r333", "r334", "r335", "r336", "r374", "r514", "r559", "r587", "r588", "r641", "r647", "r649", "r650", "r661", "r684", "r685", "r696", "r703", "r709", "r717", "r861", "r874", "r875", "r876", "r877", "r878", "r879" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "country_FI": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "FI", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Finland [Member]", "label": "FINLAND" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Assets", "label": "Assets", "terseLabel": "Total Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r141", "r190", "r218", "r256", "r265", "r269", "r309", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r429", "r433", "r453", "r540", "r609", "r715", "r729", "r857", "r858", "r872" ] }, "country_GB": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "GB", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "lang": { "en-us": { "role": { "label": "UNITED KINGDOM", "terseLabel": "British Pound Sterling [Member]", "verboseLabel": "United Kingdom [Member]" } } }, "auth_ref": [] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution." } } }, "auth_ref": [ "r221", "r222", "r349", "r366", "r478", "r689", "r690" ] }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]", "terseLabel": "Schedule of Concentrations of Credit Risk", "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r42", "r43", "r46", "r47", "r90", "r138" ] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Par Value [Member]", "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r718", "r719", "r722", "r723", "r724", "r725", "r888", "r892" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Net income attributable to MPT common stockholders (Operating Partnership partners), diluted", "totalLabel": "Earnings Per Share, Diluted, Total", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r211", "r229", "r230", "r231", "r232", "r233", "r241", "r247", "r248", "r249", "r253", "r444", "r445", "r535", "r557", "r693" ] }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average useful life of acquired intangible lease assets (in years)", "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life", "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r126" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Net Assets Acquired", "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]", "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts." } } }, "auth_ref": [ "r62", "r63" ] }, "us-gaap_GeneralPartnersCapitalAccountUnitsIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralPartnersCapitalAccountUnitsIssued", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "General partner, units issued", "label": "General Partners' Capital Account, Units Issued", "documentation": "The number of general partner units issued." } } }, "auth_ref": [ "r133" ] }, "country_CH": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "CH", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "SWITZERLAND", "terseLabel": "Switzerland [Member]" } } }, "auth_ref": [] }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "negatedLabel": "Stock vesting - satisfaction of tax withholdings", "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [ "r212" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r791" ] }, "us-gaap_ProceedsFromCollectionOfLoansReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromCollectionOfLoansReceivable", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Principal received on loans receivable", "label": "Proceeds from Collection of Loans Receivable", "documentation": "The cash inflow associated with the collection, including prepayments, of loans receivable issued for financing of goods and services." } } }, "auth_ref": [ "r33" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "auth_ref": [ "r795" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "General and Administrative Expense, Total", "terseLabel": "General and administrative", "label": "General and Administrative Expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r115", "r619" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-in Capital [Member]", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r411", "r412", "r413", "r575", "r839", "r840", "r841", "r864", "r892" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r793" ] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpenses", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total expenses", "label": "Costs and Expenses", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r113" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "auth_ref": [ "r791" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type", "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r43", "r46", "r90", "r91", "r274", "r672" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "auth_ref": [ "r791" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r731" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r791" ] }, "us-gaap_ConsolidationVariableInterestEntityPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationVariableInterestEntityPolicy", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Interest Entities", "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined)." } } }, "auth_ref": [ "r70", "r74", "r77" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r791" ] }, "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityEntityMaximumLossExposureAmount", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount", "terseLabel": "Maximum Loss Exposure", "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE)." } } }, "auth_ref": [ "r75", "r79" ] }, "us-gaap_GeographicConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeographicConcentrationRiskMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographic Concentration [Member]", "label": "Geographic Concentration Risk [Member]", "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa)." } } }, "auth_ref": [ "r45", "r672" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r792" ] }, "us-gaap_ConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebt", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Convertible Debt, Total", "label": "Convertible Debt", "terseLabel": "Convertible loan", "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company." } } }, "auth_ref": [ "r21", "r144", "r885" ] }, "us-gaap_GeneralPartnersCapitalAccountUnitsOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralPartnersCapitalAccountUnitsOutstanding", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "General partner, units outstanding", "label": "General Partners' Capital Account, Units Outstanding", "documentation": "The number of general partner units outstanding." } } }, "auth_ref": [ "r133" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r791" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "auth_ref": [ "r792" ] }, "us-gaap_GeneralPartnersCapitalAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralPartnersCapitalAccount", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "General Partner - issued and outstanding - 5,986 units at September 30, 2023 and 5,976 units at December 31, 2022", "totalLabel": "General Partners' Capital Account, Total", "label": "General Partners' Capital Account", "documentation": "The amount of the general partner's ownership interest." } } }, "auth_ref": [ "r133" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r19", "r27", "r184", "r203", "r204", "r205", "r224", "r225", "r226", "r228", "r234", "r236", "r255", "r310", "r311", "r368", "r411", "r412", "r413", "r419", "r420", "r436", "r437", "r438", "r439", "r440", "r441", "r443", "r459", "r460", "r461", "r462", "r463", "r464", "r475", "r560", "r561", "r562", "r575", "r636" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Retained Earnings (Deficit) [Member]", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r184", "r224", "r225", "r226", "r228", "r234", "r236", "r310", "r311", "r411", "r412", "r413", "r419", "r420", "r436", "r438", "r439", "r441", "r443", "r560", "r562", "r575", "r892" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r19", "r184", "r203", "r204", "r205", "r224", "r225", "r226", "r228", "r234", "r236", "r255", "r310", "r311", "r368", "r411", "r412", "r413", "r419", "r420", "r436", "r437", "r438", "r439", "r440", "r441", "r443", "r459", "r460", "r461", "r462", "r463", "r464", "r475", "r560", "r561", "r562", "r575", "r636" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "auth_ref": [ "r794" ] }, "us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "periodStartLabel": "Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]", "periodEndLabel": "Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]", "label": "Restricted Cash and Cash Equivalents, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes cash and cash equivalents restricted to withdrawal or usage." } } }, "auth_ref": [ "r216" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]", "terseLabel": "Insider Trading Arrangements:" } } }, "auth_ref": [ "r798" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r796" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r797" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive (Loss) Income [Member]", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r4", "r18", "r31", "r437", "r440", "r475", "r560", "r561", "r825", "r826", "r827", "r839", "r840", "r841" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r771" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income (expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r117" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income (expense)" } } }, "auth_ref": [] }, "us-gaap_Investments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Investments", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Investments, Total", "label": "Investments", "terseLabel": "Investments", "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments." } } }, "auth_ref": [ "r538" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r771" ] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Tangible Asset", "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r11" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r771" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Net income attributable to MPT common stockholders (Operating Partnership partners), basic", "totalLabel": "Earnings Per Share, Basic, Total", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r211", "r229", "r230", "r231", "r232", "r233", "r239", "r241", "r247", "r248", "r249", "r253", "r444", "r445", "r535", "r557", "r693" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "auth_ref": [ "r772" ] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Business Combination, Consideration Transferred, Total", "verboseLabel": "Purchase price of acquisition", "label": "Business Combination, Consideration Transferred", "terseLabel": "Funded for interim mortgage loan", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r1", "r2", "r13" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "auth_ref": [ "r772" ] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail": { "parentTag": "us-gaap_LongTermDebt", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Debt Issuance Costs, Net, Total", "negatedLabel": "Debt issue costs and discount, net", "label": "Debt Issuance Costs, Net", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r94", "r862" ] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r772" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, par value", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r102", "r365" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LimitedPartnersCapitalAccountUnitsOutstanding", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Limited Partners, units outstanding", "label": "Limited Partners' Capital Account, Units Outstanding", "documentation": "The number of limited partner units outstanding." } } }, "auth_ref": [ "r133" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total", "terseLabel": "Accounts payable and accrued expenses", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r9" ] }, "us-gaap_OtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssets", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Other assets", "terseLabel": "Other assets,net", "totalLabel": "Total other assets", "label": "Other Assets", "documentation": "Amount of assets classified as other." } } }, "auth_ref": [ "r140", "r189", "r539", "r729" ] }, "mpw_DebtRefinancingAndUnutilizedFinancingBenefitCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20230930", "localname": "DebtRefinancingAndUnutilizedFinancingBenefitCosts", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Debt refinancing and unutilized financing (benefit) costs", "label": "Debt Refinancing And Unutilized Financing (Benefit) Costs", "documentation": "Debt refinancing and unutilized financing (benefit) costs." } } }, "auth_ref": [] }, "us-gaap_LimitedPartnersCapitalAccountUnitsIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LimitedPartnersCapitalAccountUnitsIssued", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Limited Partners, units issued", "label": "Limited Partners' Capital Account, Units Issued", "documentation": "The number of limited partner units issued." } } }, "auth_ref": [ "r133" ] }, "us-gaap_LimitedPartnersCapitalAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LimitedPartnersCapitalAccount", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Limited Partners - issued and outstanding - 592,458 units at September 30, 2023 and 591,500 units at December 31, 2022", "totalLabel": "Limited Partners' Capital Account, Total", "label": "Limited Partners' Capital Account", "documentation": "The amount of the limited partners' ownership interests." } } }, "auth_ref": [ "r133" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Recurring [Member]", "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r446", "r451" ] }, "us-gaap_DirectFinancingLeaseRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DirectFinancingLeaseRevenue", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Income from financing leases", "label": "Direct Financing Lease, Revenue", "documentation": "Amount of direct financing lease revenue." } } }, "auth_ref": [ "r254", "r472" ] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDlomBySensitivityAnalysisByUsingBasisPointVariationsDetails" ], "lang": { "en-us": { "role": { "label": "Variable Rate [Domain]", "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r771" ] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDlomBySensitivityAnalysisByUsingBasisPointVariationsDetails" ], "lang": { "en-us": { "role": { "label": "Variable Rate [Axis]", "documentation": "Information by type of variable rate." } } }, "auth_ref": [] }, "us-gaap_RealEstateDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateDisclosureTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities" ], "lang": { "en-us": { "role": { "terseLabel": "Real Estate and Other Activities", "label": "Real Estate Disclosure [Text Block]", "documentation": "The entire disclosure for certain real estate investment financial statements, real estate investment trust operating support agreements, real estate owned, retail land sales, time share transactions, as well as other real estate related disclosures." } } }, "auth_ref": [ "r153", "r154", "r155", "r156", "r157" ] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Table]", "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r768" ] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Concentration Risk [Member]", "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r44", "r274" ] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Line Items]", "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 0.0 }, "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Principal amount", "totalLabel": "Total", "terseLabel": "Debt", "label": "Long-Term Debt, Gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r21", "r144", "r363" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireLoansReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireLoansReceivable", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Investment in loans receivable", "terseLabel": "Investment in loans receivable", "label": "Payments to Acquire Loans Receivable", "documentation": "The cash outflow for the purchase of loan receivable arising from the financing of goods and services." } } }, "auth_ref": [ "r34" ] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleOfProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfProductiveAssets", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Proceeds from Sale of Productive Assets, Total", "terseLabel": "Net proceeds from sale of real estate", "label": "Proceeds from Sale of Productive Assets", "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r119" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r733" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r766" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash, cash equivalents, and restricted cash are comprised of the following:", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Maximum borrowing capacity", "terseLabel": "Line of credit facility, Borrowing capacity", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r22" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock / (Unit)-based compensation expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r9" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GainLossOnSaleOfInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnSaleOfInvestments", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gains", "label": "Gain (Loss) on Sale of Investments", "totalLabel": "Gain (Loss) on Sale of Investments, Total", "documentation": "The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities." } } }, "auth_ref": [ "r10" ] }, "srt_EuropeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EuropeMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Europe [Member]", "label": "Europe [Member]", "documentation": "Continent of Europe." } } }, "auth_ref": [ "r894", "r895", "r896", "r898" ] }, "us-gaap_PaymentsToAcquireRealEstate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireRealEstate", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Payments to Acquire Real Estate, Total", "negatedLabel": "Cash paid for acquisitions and other related investments", "label": "Payments to Acquire Real Estate", "documentation": "The cash outflow from the acquisition of a piece of land, anything permanently fixed to it, including buildings, structures on it and so forth; includes real estate intended to generate income for the owner; excludes real estate acquired for use by the owner." } } }, "auth_ref": [ "r120" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]", "documentation": "Information by name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r306", "r307", "r308" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of intangibles", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r10", "r49", "r52" ] }, "us-gaap_InvestmentOwnedAtCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentOwnedAtCost", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Original Cost", "terseLabel": "Book value", "label": "Investment Owned, Cost", "documentation": "Cost of the investment." } } }, "auth_ref": [ "r569", "r584", "r585", "r644", "r646", "r653", "r663", "r720", "r729", "r889" ] }, "us-gaap_AccountsNotesAndLoansReceivableLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsNotesAndLoansReceivableLineItems", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesCreditLossReservesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r223", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r468", "r698", "r699", "r700", "r701", "r702", "r835" ] }, "us-gaap_FinancingReceivableAllowanceForCreditLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancingReceivableAllowanceForCreditLosses", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfActivityInCreditLossReservesDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Allowance for Credit Loss", "periodEndLabel": "Balance at end of the period", "periodStartLabel": "Balance at beginning of the period", "documentation": "Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement." } } }, "auth_ref": [ "r14", "r169", "r170", "r171", "r192", "r312", "r315", "r318", "r881" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r21", "r99", "r100", "r142", "r144", "r223", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r468", "r698", "r699", "r700", "r701", "r702", "r835" ] }, "srt_SouthAmericaMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SouthAmericaMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "South America [Member]", "label": "South America [Member]", "documentation": "Continent of South America." } } }, "auth_ref": [ "r894", "r895", "r896", "r898" ] }, "us-gaap_BusinessCombinationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationsAbstract", "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r26", "r57", "r58", "r92", "r93", "r95", "r97", "r130", "r131", "r223", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r468", "r698", "r699", "r700", "r701", "r702", "r835" ] }, "us-gaap_InvestmentTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTypeAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Investment Type", "label": "Investment Type [Axis]", "documentation": "Information by type of investments." } } }, "auth_ref": [ "r579", "r581", "r582", "r584", "r586", "r640", "r642", "r648", "r652", "r654", "r657", "r658", "r664", "r666", "r667", "r668", "r669", "r720" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 21.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "negatedLabel": "Deferred revenue", "label": "Increase (Decrease) in Contract with Customer, Liability", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r515", "r832" ] }, "us-gaap_LongTermDebtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtFairValue", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail" ], "lang": { "en-us": { "role": { "negatedLabel": "Debt, net Fair value", "label": "Long-Term Debt, Fair Value", "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission." } } }, "auth_ref": [] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r103" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Debt", "label": "Schedule of Debt [Table Text Block]", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation (loss) gain", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "verboseLabel": "Foreign currency translation (loss) gain", "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r5", "r109", "r454", "r455", "r458" ] }, "us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from effective portion of derivative instrument reclassified from accumulated other comprehensive income (AOCI) into income." } } }, "auth_ref": [ "r435" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical", "label": "Geographical [Domain]", "documentation": "Geographical area." } } }, "auth_ref": [ "r172", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r272", "r273", "r580", "r583", "r585", "r642", "r648", "r654", "r664", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r686", "r704", "r720", "r863", "r886" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark", "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r43", "r46", "r90", "r91", "r274", "r672" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r731" ] }, "us-gaap_ForeignCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCountryMember", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Foreign Tax Authority [Member]", "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://medicalpropertiestrust.com/20230930/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark", "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r43", "r46", "r90", "r91", "r274", "r566", "r672" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a-c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-16" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(c)(1)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(c)(2)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(2)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.3,4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//310-10/tableOfContent" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB TOPIC 4.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "55", "Paragraph": "37", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "2AA", "Subparagraph": "a", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-2AA" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Subparagraph": "b", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-9" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(1),(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 4.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-23" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.11)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "970", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//970/tableOfContent" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "972", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//972/tableOfContent" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "974", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//974/tableOfContent" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "976", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//976/tableOfContent" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "978", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//978/tableOfContent" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481178/840-20-25-1" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481178/840-20-25-2" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481123/840-20-35-2" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-4" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "SubTopic": "360", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479638/944-360-45-3" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "SubTopic": "360", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479638/944-360-45-4" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "360", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479607/944-360-50-1" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-7A" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(2))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "(a)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "(a)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "(c)", "Publisher": "SEC" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Footnote": "2", "Publisher": "SEC" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Footnote": "4", "Publisher": "SEC" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column B", "Publisher": "SEC" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column C", "Publisher": "SEC" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column D", "Publisher": "SEC" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column E", "Publisher": "SEC" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column F", "Publisher": "SEC" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column G", "Publisher": "SEC" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column H", "Publisher": "SEC" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column I", "Publisher": "SEC" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Footnote": "4", "Publisher": "SEC" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "4", "Subsection": "08", "Paragraph": "(m)", "Subparagraph": "(1)(iii)", "Publisher": "SEC" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-17A" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-21D" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482964/270-10-50-6A" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-5A" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-9" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-3" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "40", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481724/830-30-40-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-12" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479016/842-30-45-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-3" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-5" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-5" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-6" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-7" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(h))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-3" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "19", "Subparagraph": "(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5D", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5D", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 5)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r686": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r687": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16" }, "r689": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21" }, "r690": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r691": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r692": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r694": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r695": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r696": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r697": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8" }, "r698": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r699": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r700": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r701": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r702": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r703": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r704": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r705": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r706": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r707": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r708": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r709": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r710": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r711": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r712": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r713": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r714": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r715": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r716": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r717": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r718": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r720": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r721": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r722": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r723": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r724": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r725": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r726": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "405", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480191/946-405-45-2" }, "r727": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r728": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r729": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r730": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r731": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r732": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r733": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r734": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r735": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r736": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r737": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r738": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r739": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r740": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r741": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r742": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r743": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r744": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r745": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r746": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r747": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r748": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r749": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r750": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r751": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r752": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r753": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r754": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r755": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r756": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r757": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r758": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r759": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r760": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r761": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r762": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r763": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r764": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r765": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r766": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r767": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r768": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r769": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r770": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r771": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r772": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r773": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r774": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r775": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r776": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r777": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r778": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r779": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r780": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r781": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r782": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r783": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r784": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r785": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r786": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r787": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r788": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r789": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r790": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r791": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r792": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r793": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r794": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r795": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r796": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r797": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r798": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r799": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r800": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r801": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r802": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r803": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r804": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r805": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r806": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10" }, "r807": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3" }, "r808": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r809": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r810": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r811": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r812": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r813": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r814": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r815": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r816": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r817": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r818": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r819": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r820": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "11", "Subsection": "03", "Publisher": "SEC" }, "r821": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r822": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r823": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r824": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1" }, "r825": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r826": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r827": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r828": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(7)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r829": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(9)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r830": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r831": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r832": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r833": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r834": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r835": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r836": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r837": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(S-X 210.12-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r838": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r839": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r840": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r841": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r842": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r843": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r844": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r845": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r846": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r847": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r848": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r849": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r850": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r851": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r852": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r853": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2" }, "r854": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r855": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r856": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r857": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r858": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r859": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r860": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r861": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r862": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r863": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r864": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r865": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r866": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r867": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r868": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r869": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479341/842-30-25-11" }, "r870": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-3" }, "r871": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r872": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r873": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r874": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r877": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r878": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r879": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r880": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r881": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(7)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r882": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(14)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r883": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r884": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r885": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r886": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r887": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r888": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r889": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r890": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r891": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r892": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r893": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r894": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r895": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r896": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r897": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r898": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" } } }